Partners	O
in	O
transcription	O
:	O
NFAT	B-protein
and	O
AP-1	B-protein
.	O

Combinatorial	O
regulation	O
is	O
a	O
powerful	O
mechanism	O
that	O
enables	O
tight	O
control	O
of	O
gene	O
expression	O
,	O
via	O
integration	O
of	O
multiple	O
signaling	O
pathways	O
that	O
induce	O
different	O
transcription	B-protein
factors	I-protein
required	O
for	O
enhanceosome	O
assembly	O
.	O

The	O
four	O
calcium-regulated	O
transcription	B-protein
factors	I-protein
of	O
the	O
NFAT	B-protein
family	I-protein
act	O
synergistically	O
with	O
AP-1	B-protein
(	I-protein
Fos/Jun	I-protein
)	I-protein
proteins	I-protein
on	O
composite	O
DNA	O
elements	O
which	O
contain	O
adjacent	O
NFAT	B-DNA
and	I-DNA
AP-1	I-DNA
binding	I-DNA
sites	I-DNA
,	O
where	O
they	O
form	O
highly	O
stable	O
ternary	O
complexes	O
to	O
regulate	O
the	O
expression	O
of	O
diverse	O
inducible	O
genes	O
.	O

Concomitant	O
induction	O
of	O
NFAT	B-protein
and	O
AP-1	B-protein
requires	O
concerted	O
activation	O
of	O
two	O
different	O
signaling	O
pathways	O
:	O
calcium/calcineurin	O
,	O
which	O
promotes	O
NFAT	O
dephosphorylation	O
,	O
nuclear	O
translocation	O
and	O
activation	O
;	O
and	O
protein	B-protein
kinase	I-protein
C	I-protein
(	I-protein
PKC	I-protein
)	I-protein
/Ras	I-protein
,	O
which	O
promotes	O
the	O
synthesis	O
,	O
phosphorylation	O
and	O
activation	O
of	O
members	O
of	O
the	O
Fos	B-protein
and	I-protein
Jun	I-protein
families	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

A	O
fifth	O
member	O
of	O
the	O
NFAT	B-protein
family	I-protein
,	O
NFAT5	B-protein
,	O
controls	O
the	O
cellular	O
response	O
to	O
osmotic	O
stress	O
,	O
by	O
a	O
mechanism	O
that	O
requires	O
dimer	O
formation	O
and	O
is	O
independent	O
of	O
calcineurin	B-protein
or	O
of	O
interaction	O
with	O
AP-1	B-protein
.	O

Pharmacological	O
interference	O
with	O
theNFAT	O
:	O
AP-1	O
interaction	O
may	O
be	O
useful	O
in	O
selective	O
manipulation	O
of	O
the	O
immune	O
response	O
.	O

Balanced	O
activation	O
of	O
NFAT	B-protein
and	O
AP-1	B-protein
is	O
known	O
to	O
be	O
required	O
for	O
productive	O
immune	O
responses	O
,	O
but	O
the	O
role	O
of	O
NFAT	O
:	O
AP-1	O
interactions	O
in	O
other	O
cell	O
types	O
and	O
biological	O
processes	O
remains	O
to	O
be	O
understood	O
.	O

a	NULL
Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
2476-2489	NULL
©	NULL
2001	NULL
Nature	NULL
Publishing	NULL
Group	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/01	NULL
$	NULL
15.00	NULL
www.nature.com/onc	NULL
Partners	NULL
in	NULL
transcription	NULL
:	NULL
NFAT	NULL
and	NULL
AP-1	NULL
Fernando	NULL
Macian	NULL
'	NULL
,	NULL
Cristina	NULL
Lopez-Rodriguez	NULL
'	NULL
and	NULL
Anjana	NULL
Rao*	NULL
``	NULL
'Department	NULL
of	NULL
Pathology	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
and	NULL
the	NULL
Center	NULL
for	NULL
Blood	NULL
Research	NULL
,	NULL
200	NULL
Longwood	NULL
Avenue	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
,	NULL
MA	NULL
02115	NULL
,	NULL
USA	NULL
Combinatorial	NULL
regulation	NULL
is	NULL
a	NULL
powerful	NULL
mechanism	NULL
that	NULL
enables	NULL
tight	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
via	NULL
integration	NULL
of	NULL
multiple	NULL
signaling	NULL
pathways	NULL
that	NULL
induce	NULL
different	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
enhanceosome	NULL
assem-bly	NULL
.	NULL

The	NULL
four	NULL
calcium-regulated	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
act	NULL
synergistically	NULL
with	NULL
AP-1	NULL
(	NULL
Fos/	NULL
Jun	NULL
)	NULL
proteins	NULL
on	NULL
composite	NULL
DNA	NULL
elements	NULL
which	NULL
contain	NULL
adjacent	NULL
NFAT	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
where	NULL
they	NULL
form	NULL
highly	NULL
stable	NULL
ternary	NULL
complexes	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
diverse	NULL
inducible	NULL
genes	NULL
.	NULL

Concomitant	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
requires	NULL
concerted	NULL
activation	NULL
of	NULL
two	NULL
different	NULL
signaling	NULL
pathways	NULL
:	NULL
calcium/calcineurin	NULL
,	NULL
which	NULL
promotes	NULL
NFAT	NULL
dephosphorylation	NULL
,	NULL
nuclear	NULL
translocation	NULL
and	NULL
activation	NULL
;	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
/Ras	NULL
,	NULL
which	NULL
promotes	NULL
the	NULL
synthesis	NULL
,	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
fifth	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
,	NULL
NFATS5	NULL
,	NULL
controls	NULL
the	NULL
cellular	NULL
response	NULL
to	NULL
osmotic	NULL
stress	NULL
,	NULL
by	NULL
a	NULL
mechanism	NULL
that	NULL
requires	NULL
dimer	NULL
formation	NULL
and	NULL
is	NULL
independent	NULL
of	NULL
calcineurin	NULL
or	NULL
of	NULL
interaction	NULL
with	NULL
AP-1	NULL
.	NULL

Pharmacological	NULL
interference	NULL
with	NULL
the	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interaction	NULL
may	NULL
be	NULL
useful	NULL
in	NULL
selective	NULL
manipulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

Balanced	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
required	NULL
for	NULL
productive	NULL
immune	NULL
responses	NULL
,	NULL
but	NULL
the	NULL
role	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interactions	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
and	NULL
biological	NULL
processes	NULL
remains	NULL
to	NULL
be	NULL
understood	NULL
.	NULL

Oncogene	NULL
(	NULL
2001	NULL
)	NULL
20	NULL
,	NULL
2476-2489	NULL
.	NULL

Keywords	NULL
:	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
Fos	NULL
;	NULL
Jun	NULL
;	NULL
transcriptional	NULL
regulation	NULL
Introduction	NULL
Regulation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
eukaryotes	NULL
is	NULL
achieved	NULL
by	NULL
coordinate	NULL
assembly	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
and	NULL
DNA-binding	NULL
proteins	NULL
onto	NULL
specific	NULL
DNA	NULL
regulatory	NULL
regions	NULL
that	NULL
control	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
resulting	NULL
multiprotein-DNA	NULL
complexes	NULL
have	NULL
a	NULL
precise	NULL
sterospecific	NULL
architecture	NULL
and	NULL
have	NULL
been	NULL
termed	NULL
en-hanceosomes	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
diverse	NULL
transcription	NULL
factors	NULL
within	NULL
enhanceosomes	NULL
ensures	NULL
a	NULL
strict	NULL
temporal	NULL
and	NULL
tissue-specific	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
each	NULL
of	NULL
the	NULL
factors	NULL
needs	NULL
to	NULL
be	NULL
present	NULL
within	NULL
the	NULL
relevant	NULL
cell	NULL
type	NULL
and	NULL
also	NULL
correctly	NULL
activated	NULL
to	NULL
permit	NULL
enhanceosome	NULL
assembly	NULL
and	NULL
consequent	NULL
gene	NULL
tran	NULL
*Correspondence	NULL
:	NULL
A	NULL
Rao	NULL
scription	NULL
.	NULL

The	NULL
resulting	NULL
requirement	NULL
for	NULL
integration	NULL
of	NULL
multiple	NULL
signaling	NULL
pathways	NULL
,	NULL
leading	NULL
to	NULL
optimal	NULL
activation	NULL
of	NULL
each	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
within	NULL
the	NULL
enhanceosome	NULL
complex	NULL
,	NULL
explains	NULL
how	NULL
ubiquitous	NULL
signaling	NULL
intermediates	NULL
promote	NULL
the	NULL
initiation	NULL
of	NULL
very	NULL
specific	NULL
biological	NULL
responses	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
different	NULL
receptors	NULL
within	NULL
the	NULL
same	NULL
cell	NULL
,	NULL
or	NULL
the	NULL
same	NULL
receptors	NULL
expressed	NULL
on	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Assembly	NULL
of	NULL
synergistic	NULL
transcription	NULL
factors	NULL
on	NULL
promoters	NULL
or	NULL
enhancers	NULL
can	NULL
occur	NULL
as	NULL
a	NULL
simple	NULL
independent	NULL
binding	NULL
of	NULL
different	NULL
proteins	NULL
to	NULL
adjacent	NULL
binding	NULL
sites	NULL
,	NULL
or	NULL
involve	NULL
a	NULL
further	NULL
degree	NULL
of	NULL
control	NULL
in	NULL
what	NULL
have	NULL
been	NULL
termed	NULL
composite	NULL
DNA	NULL
elements	NULL
.	NULL

Binding	NULL
on	NULL
these	NULL
composite	NULL
elements	NULL
involves	NULL
not	NULL
only	NULL
functional	NULL
synergy	NULL
but	NULL
the	NULL
existence	NULL
of	NULL
cooperative	NULL
physical	NULL
interactions	NULL
between	NULL
two	NULL
or	NULL
more	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
result	NULL
is	NULL
a	NULL
DNA-bound	NULL
complex	NULL
containing	NULL
several	NULL
proteins	NULL
,	NULL
that	NULL
overall	NULL
is	NULL
much	NULL
more	NULL
stable	NULL
than	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
any	NULL
of	NULL
its	NULL
individual	NULL
components	NULL
bound	NULL
independently	NULL
to	NULL
the	NULL
composite	NULL
DNA	NULL
site	NULL
.	NULL

Among	NULL
the	NULL
pairs	NULL
of	NULL
unrelated	NULL
transcription	NULL
factors	NULL
that	NULL
have	NULL
been	NULL
found	NULL
to	NULL
bind	NULL
cooperatively	NULL
to	NULL
composite	NULL
DNA	NULL
sites	NULL
,	NULL
one	NULL
of	NULL
the	NULL
best	NULL
well-known	NULL
examples	NULL
is	NULL
the	NULL
ternary	NULL
NFAT	NULL
:	NULL
AP-1	NULL
complex	NULL
that	NULL
contains	NULL
proteins	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
and	NULL
AP-	NULL
families	NULL
.	NULL

Composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
in	NULL
numerous	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
productive	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NFAT	NULL
proteins	NULL
is	NULL
regulated	NULL
by	NULL
calcium	NULL
and	NULL
calcineurin	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
AP-1	NULL
proteins	NULL
is	NULL
regulated	NULL
by	NULL
other	NULL
pathways	NULL
including	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
and	NULL
Ras	NULL
.	NULL

Cooperation	NULL
between	NULL
these	NULL
two	NULL
unrelated	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
constitutes	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
these	NULL
two	NULL
distinct	NULL
signaling	NULL
pathways	NULL
are	NULL
integrated	NULL
to	NULL
produce	NULL
a	NULL
biological	NULL
response	NULL
.	NULL

Depending	NULL
on	NULL
whether	NULL
or	NULL
not	NULL
both	NULL
transcription	NULL
factors	NULL
are	NULL
concomitantly	NULL
activated	NULL
,	NULL
distinct	NULL
sets	NULL
of	NULL
genes	NULL
may	NULL
be	NULL
activated	NULL
,	NULL
eliciting	NULL
different	NULL
patterns	NULL
of	NULL
cellular	NULL
response	NULL
.	NULL

The	NULL
NFAT	NULL
family	NULL
Five	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
identified	NULL
so	NULL
far	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
classical	NULL
members	NULL
of	NULL
this	NULL
family	NULL
comprise	NULL
NFAT1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
NFATp	NULL
or	NULL
NFATc2	NULL
)	NULL
(	NULL
McCaf-frey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
NFAT2	NULL
(	NULL
NFATe	NULL
or	NULL
NFATecl	NULL
)	NULL
(	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
NFAT3	NULL
(	NULL
NFATc4	NULL
)	NULL
Hoey	NULL
et	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
Table	NULL
1	NULL
The	NULL
NFAT	NULL
family	NULL
Domain	NULL
organization	NULL
NFAT	NULL
protein	NULL
.	NULL

Other	NULL
names	NULL
TAD	NULL
Regulatory	NULL
__	NULL
DNA	NULL
binding	NULL
__	NULL
NFATA	NULL
NFATp	NULL
,	NULL
NFATe2	NULL
|	NULL
__LAZLZLILILLLILA	NULL
[	NULL
_______	NULL
NFAT2	NULL
NFATe	NULL
,	NULL
NFATe1	NULL
m	NULL
NFAT3	NULL
NFATeA4	NULL
[	NULL
_______	NULL
]	NULL
NFATA	NULL
NFATx	NULL
,	NULL
NFATe3	NULL
__	NULL
[	NULL
___|	NULL
NFAT5	NULL
NFATZ	NULL
,	NULL
NFATL1	NULL
,	NULL
TonEBP	NULL
av	NULL
“	NULL
xxx-	NULL
“	NULL
mm	NULL
“	NULL
?	NULL

NFAT	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
-	NULL
Phenotype	NULL
of	NULL
knockout	NULL
mice	NULL
NFAT	NULL
Moderately	NULL
enhanced	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
responses	NULL
with	NULL
a	NULL
bias	NULL
towards	NULL
increased	NULL
production	NULL
of	NULL
IL-4	NULL
and	NULL
other	NULL
Th2	NULL
cytokines	NULL
.	NULL

Embryonic	NULL
lethal	NULL
(	NULL
defect	NULL
in	NULL
cardiac	NULL
valve	NULL
development	NULL
)	NULL
.	NULL

NFAT2	NULL
In	NULL
RAG	NULL
blastocyst	NULL
complementation	NULL
system	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
show	NULL
reduced	NULL
proliferative	NULL
response	NULL
and	NULL
moderately	NULL
impaired	NULL
Th2	NULL
response	NULL
with	NULL
decreased	NULL
IL-4	NULL
production	NULL
.	NULL

NFAT3	NULL
Not	NULL
reported	NULL
yet	NULL
Mildly	NULL
impaired	NULL
development	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
single	NULL
positive	NULL
thymocytes	NULL
due	NULL
to	NULL
increased	NULL
apoptosis	NULL
of	NULL
double	NULL
NFAT4	NULL
a	NULL
¥	NULL
mas	NULL
:	NULL
.	NULL

positive	NULL
thymocytes	NULL
.	NULL

Mild	NULL
hyperactivation	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

NFATS5	NULL
Not	NULL
reported	NULL
yet	NULL
.	NULL

In	NULL
fetal	NULL
liver	NULL
chimeras	NULL
,	NULL
T	NULL
cells	NULL
show	NULL
impaired	NULL
effector	NULL
functions	NULL
with	NULL
severely	NULL
reduced	NULL
production	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
NFAT1+NFAT2	NULL
8	NULL
<	NULL
.	NULL

cytokines	NULL
.	NULL

Paradoxically	NULL
B	NULL
,	NULL
cells	NULL
are	NULL
hyperreactive	NULL
.	NULL

NFAT1+NFATA4	NULL
Lymphoproliferative	NULL
disorder	NULL
due	NULL
to	NULL
TCR	NULL
hyperreactivity	NULL
and	NULL
defects	NULL
in	NULL
T	NULL
cell	NULL
apoptosis	NULL
.	NULL

Increased	NULL
Th2	NULL
responses	NULL
with	NULL
allergic	NULL
blefaritis	NULL
and	NULL
interstitial	NULL
pneumonitis	NULL
.	NULL

al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
NFAT4	NULL
(	NULL
NFATx	NULL
or	NULL
NFATec3	NULL
)	NULL
(	NULL
Hoey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Masuda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Recently	NULL
a	NULL
new	NULL
NFAT	NULL
member	NULL
with	NULL
special	NULL
characteristics	NULL
was	NULL
cloned	NULL
in	NULL
two	NULL
independent	NULL
laboratories	NULL
,	NULL
who	NULL
named	NULL
it	NULL
NFATS5	NULL
and	NULL
TonEBP	NULL
respectively	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
;	NULL
Miyakawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

All	NULL
five	NULL
NFAT	NULL
proteins	NULL
share	NULL
a	NULL
Rel-like	NULL
homology	NULL
region	NULL
and	NULL
recognize	NULL
similar	NULL
DNA	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
numerous	NULL
genes	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NFATS5	NULL
possesses	NULL
several	NULL
specific	NULL
features	NULL
that	NULL
differentiate	NULL
it	NULL
from	NULL
the	NULL
classical	NULL
NFAT1I-4	NULL
members	NULL
,	NULL
amongst	NULL
them	NULL
its	NULL
inability	NULL
to	NULL
form	NULL
cooperative	NULL
complexes	NULL
with	NULL
AP-1	NULL
proteins	NULL
on	NULL
composite	NULL
DNA	NULL
elements	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
NFATS5	NULL
will	NULL
be	NULL
discussed	NULL
separately	NULL
at	NULL
the	NULL
end	NULL
of	NULL
this	NULL
review	NULL
,	NULL
and	NULL
the	NULL
term	NULL
NFAT	NULL
will	NULL
be	NULL
used	NULL
,	NULL
in	NULL
many	NULL
but	NULL
not	NULL
all	NULL
cases	NULL
,	NULL
to	NULL
refer	NULL
only	NULL
to	NULL
the	NULL
four	NULL
conventional	NULL
NFAT	NULL
proteins	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
conventional	NULL
NFAT	NULL
proteins	NULL
contains	NULL
a	NULL
moderately-conserved	NULL
regulatory	NULL
domain	NULL
in	NULL
its	NULL
N-terminal	NULL
region	NULL
,	NULL
that	NULL
controls	NULL
NFAT	NULL
cellular	NULL
distribution	NULL
and	NULL
transcriptional	NULL
activation	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Beals	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997b	NULL
;	NULL
Crabtree	NULL
,	NULL
1999	NULL
;	NULL
Kiani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996a	NULL
;	NULL
Zhu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
highly	NULL
phosphorylated	NULL
on	NULL
multiple	NULL
serine	NULL
residues	NULL
in	NULL
resting	NULL
cells	NULL
;	NULL
upon	NULL
cell	NULL
activation	NULL
it	NULL
is	NULL
dephosphorylated	NULL
by	NULL
the	NULL
calcium/calmodulin-depen-dent	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
the	NULL
major	NULL
upstream	NULL
regulator	NULL
of	NULL
NFAT	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Beals	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997a	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
;	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996a	NULL
;	NULL
Shibasaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Immediately	NULL
adjacent	NULL
to	NULL
the	NULL
regulatory	NULL
domain	NULL
lies	NULL
the	NULL
highly-conserved	NULL
NFAT	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
distantly	NULL
related	NULL
in	NULL
its	NULL
primary	NULL
sequence	NULL
but	NULL
shows	NULL
a	NULL
strong	NULL
structural	NULL
similarity	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
(	NULL
Rel	NULL
homology	NULL
region	NULL
)	NULL
of	NULL
the	NULL
Rel/NF-xB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
;	NULL
Nolan	NULL
,	NULL
1994	NULL
;	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
discussed	NULL
in	NULL
detail	NULL
below	NULL
,	NULL
NFAT	NULL
DNA-binding	NULL
domains	NULL
can	NULL
not	NULL
only	NULL
bind	NULL
cooperatively	NULL
to	NULL
DNA	NULL
with	NULL
AP-1	NULL
,	NULL
but	NULL
also	NULL
can	NULL
form	NULL
Rel/NF-xB-like	NULL
dimers	NULL
on	NULL
certain	NULL
types	NULL
of	NULL
NFAT-binding	NULL
DNA	NULL
elements	NULL
(	NULL
Kinoshita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Macian	NULL
and	NULL
Rao	NULL
,	NULL
1999	NULL
;	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
pairwise	NULL
comparisons	NULL
of	NULL
the	NULL
different	NULL
NFAT	NULL
and	NULL
NF-xB	NULL
family	NULL
members	NULL
,	NULL
the	NULL
DNA-binding	NULL
domain	NULL
shows	NULL
60-70	NULL
%	NULL
sequence	NULL
identity	NULL
among	NULL
the	NULL
classical	NULL
NFAT	NULL
proteins	NULL
,	NULL
~40	NULL
%	NULL
sequence	NULL
identity	NULL
between	NULL
these	NULL
proteins	NULL
and	NULL
NFAT5	NULL
,	NULL
and	NULL
only	NULL
15-17	NULL
%	NULL
sequence	NULL
identity	NULL
between	NULL
individual	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
families	NULL
.	NULL

Transcriptional	NULL
activation	NULL
domains	NULL
have	NULL
been	NULL
mapped	NULL
to	NULL
both	NULL
the	NULL
amino-	NULL
and	NULL
carboxy-	NULL
terminal	NULL
regions	NULL
of	NULL
different	NULL
NFAT	NULL
proteins	NULL
(	NULL
Avots	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19962	NULL
)	NULL
.	NULL

NFAT1	NULL
,	NULL
2	NULL
and	NULL
4	NULL
are	NULL
expressed	NULL
mainly	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
where	NULL
they	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulating	NULL
a	NULL
large	NULL
number	NULL
of	NULL
inducible	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

The	NULL
known	NULL
NFAT	NULL
target	NULL
genes	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
are	NULL
described	NULL
in	NULL
a	NULL
later	NULL
section	NULL
.	NULL

Mice	NULL
that	NULL
are	NULL
deficient	NULL
for	NULL
both	NULL
and	NULL
NFAT4	NULL
show	NULL
a	NULL
striking	NULL
allergic	NULL
phenotype	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
these	NULL
two	NULL
proteins	NULL
in	NULL
suppressing	NULL
production	NULL
of	NULL
the	NULL
2477	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2478	NULL
C-TERMINAL	NULL
TAD-N	NULL
REGULATORY	NULL
<	NULL
-	NULL
>	NULL
<	NULL
4	NULL
calcineurin	NULL
mands	NULL
docking	NULL
-	NULL
serine-rich	NULL
gatekeeper	NULL
region	NULL
DNA-BINDING	NULL
<	NULL
6	NULL
400	NULL
Figure	NULL
1	NULL
Domain	NULL
structure	NULL
and	NULL
phosphorylation	NULL
of	NULL
NFAT	NULL
proteins	NULL
.	NULL

The	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
TAD-N	NULL
)	NULL
,	NULL
regulatory	NULL
domain	NULL
,	NULL
DNA	NULL
binding-domain	NULL
and	NULL
C-terminal	NULL
domain	NULL
of	NULL
NFAT	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

Some	NULL
forms	NULL
of	NULL
the	NULL
proteins	NULL
have	NULL
altered	NULL
N-termini	NULL
or	NULL
are	NULL
truncated	NULL
at	NULL
their	NULL
C-termini	NULL
due	NULL
to	NULL
alternative	NULL
splicing	NULL
.	NULL

The	NULL
regulatory	NULL
domain	NULL
is	NULL
enlarged	NULL
to	NULL
show	NULL
conserved	NULL
sequence	NULL
motifs	NULL
as	NULL
colored	NULL
boxes	NULL
:	NULL
two	NULL
serine-rich	NULL
regions	NULL
(	NULL
SRR-1	NULL
and	NULL
SRR-2	NULL
)	NULL
,	NULL
three	NULL
SPxx	NULL
repeat	NULL
motifs	NULL
(	NULL
SP-1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
)	NULL
,	NULL
a	NULL
major	NULL
calcineurin	NULL
docking	NULL
site	NULL
(	NULL
PxIxIT	NULL
)	NULL
,	NULL
a	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
NLS	NULL
)	NULL
,	NULL
and	NULL
a	NULL
conserved	NULL
YRE/D	NULL
sequence	NULL
that	NULL
forms	NULL
part	NULL
of	NULL
the	NULL
gatekeeper	NULL
region	NULL
(	NULL
YRE	NULL
)	NULL
.	NULL

Phosphorylated	NULL
residues	NULL
are	NULL
shown	NULL
as	NULL
filled	NULL
circles	NULL
based	NULL
on	NULL
data	NULL
from	NULL
NFAT1	NULL
(	NULL
Okamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
:	NULL
conserved	NULL
phosphoserines	NULL
that	NULL
become	NULL
dephosphorylated	NULL
upon	NULL
activation	NULL
are	NULL
shown	NULL
in	NULL
red	NULL
,	NULL
non-conserved	NULL
phosphoserines	NULL
in	NULL
gray	NULL
,	NULL
the	NULL
conserved	NULL
phosphoserine	NULL
situated	NULL
N-terminal	NULL
to	NULL
the	NULL
NLS	NULL
in	NULL
black	NULL
;	NULL
and	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
site	NULL
in	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
in	NULL
green	NULL
specific	NULL
cytokines	NULL
that	NULL
control	NULL
the	NULL
development	NULL
of	NULL
allergy	NULL
(	NULL
Ranger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998b	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
cells	NULL
deficient	NULL
in	NULL
both	NULL
NFAT1	NULL
and	NULL
NFAT2	NULL
are	NULL
essentially	NULL
incapable	NULL
of	NULL
cytokine	NULL
production	NULL
,	NULL
but	NULL
B	NULL
cells	NULL
from	NULL
these	NULL
mice	NULL
show	NULL
an	NULL
unprecedented	NULL
phenotype	NULL
of	NULL
hyperproliferation	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
NFAT	NULL
in	NULL
suppressing	NULL
B-cell	NULL
responses	NULL
(	NULL
Peng	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2001	NULL
)	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

All	NULL
five	NULL
NFAT	NULL
proteins	NULL
are	NULL
also	NULL
expressed	NULL
in	NULL
various	NULL
non-lymphoid	NULL
tissues	NULL
,	NULL
where	NULL
they	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
diverse	NULL
cellular	NULL
functions	NULL
in	NULL
organs	NULL
other	NULL
than	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

The	NULL
functions	NULL
of	NULL
NFAT	NULL
proteins	NULL
in	NULL
extra-immune	NULL
tissues	NULL
have	NULL
been	NULL
largely	NULL
inferred	NULL
from	NULL
the	NULL
phenotypes	NULL
of	NULL
gene-disrupted	NULL
mice	NULL
lacking	NULL
individual	NULL
or	NULL
multiple	NULL
family	NULL
members	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
only	NULL
a	NULL
few	NULL
target	NULL
genes	NULL
is	NULL
known	NULL
.	NULL

Thus	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
NFAT2	NULL
gene	NULL
results	NULL
in	NULL
intrauterine	NULL
death	NULL
of	NULL
the	NULL
NFAT2-deficient	NULL
embryos	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
cardiac	NULL
valve	NULL
formation	NULL
(	NULL
Delapompa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Ranger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998a	NULL
)	NULL
.	NULL

In	NULL
muscle	NULL
tissue	NULL
NFAT2	NULL
is	NULL
thought	NULL
to	NULL
cooperate	NULL
with	NULL
GATA	NULL
to	NULL
induce	NULL
myocyte	NULL
hypertrophy	NULL
(	NULL
Musaro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

NFAT3	NULL
is	NULL
expressed	NULL
in	NULL
hippocampal	NULL
neurons	NULL
where	NULL
it	NULL
induces	NULL
transcription	NULL
of	NULL
NFAT	NULL
dependent	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
depolarization	NULL
(	NULL
Graef	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

A	NULL
calcineurin-dependent	NULL
pathway	NULL
that	NULL
induces	NULL
cardiac	NULL
hypertrophy	NULL
and	NULL
involves	NULL
a	NULL
possible	NULL
NFAT3-GATAA4	NULL
cooperation	NULL
has	NULL
also	NULL
been	NULL
described	NULL
(	NULL
Molkentin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
NFAT	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
chondrogenesis	NULL
and	NULL
adipogenesis	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Ranger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Whether	NULL
these	NULL
extra-immune	NULL
NFAT-regulated	NULL
processes	NULL
require	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
,	NULL
or	NULL
whether	NULL
Oncogene	NULL
new	NULL
transcriptional	NULL
partners	NULL
such	NULL
as	NULL
GATA	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
NFAT	NULL
activity	NULL
outside	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Signaling	NULL
pathways	NULL
that	NULL
modulate	NULL
NFAT	NULL
activity	NULL
Combinatorial	NULL
regulation	NULL
is	NULL
a	NULL
powerful	NULL
mechanism	NULL
that	NULL
allows	NULL
the	NULL
generation	NULL
of	NULL
specific	NULL
,	NULL
tightly-controlled	NULL
responses	NULL
through	NULL
integration	NULL
of	NULL
independent	NULL
signaling	NULL
pathways	NULL
that	NULL
activate	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
target	NULL
genes	NULL
that	NULL
require	NULL
the	NULL
cooperative	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interaction	NULL
will	NULL
be	NULL
expressed	NULL
only	NULL
when	NULL
there	NULL
is	NULL
coordinate	NULL
activation	NULL
of	NULL
calcium	NULL
and	NULL
MAP	NULL
kinase/protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathways	NULL
,	NULL
that	NULL
are	NULL
required	NULL
to	NULL
turn	NULL
on	NULL
NFAT	NULL
and	NULL
AP-1	NULL
respectively	NULL
.	NULL

While	NULL
NFAT	NULL
activation	NULL
requires	NULL
calcium	NULL
signaling	NULL
,	NULL
activation	NULL
of	NULL
AP-1	NULL
proteins	NULL
is	NULL
induced	NULL
by	NULL
engagement	NULL
of	NULL
a	NULL
different	NULL
signaling	NULL
pathway	NULL
that	NULL
involves	NULL
PKC	NULL
,	NULL
the	NULL
small	NULL
G	NULL
protein	NULL
Ras	NULL
,	NULL
and	NULL
several	NULL
MAP	NULL
kinases	NULL
including	NULL
JNK	NULL
and	NULL
ERK	NULL
.	NULL

The	NULL
specific	NULL
signaling	NULL
cascades	NULL
involved	NULL
are	NULL
reviewed	NULL
in	NULL
detail	NULL
elsewhere	NULL
in	NULL
this	NULL
issue	NULL
,	NULL
and	NULL
will	NULL
not	NULL
be	NULL
considered	NULL
here	NULL
except	NULL
to	NULL
note	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
relevant	NULL
protein	NULL
kinase	NULL
C	NULL
appears	NULL
to	NULL
be	NULL
PKCO	NULL
(	NULL
Altman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Calcium	NULL
and	NULL
store-operated	NULL
calcium	NULL
entry	NULL
Activation	NULL
of	NULL
NFAT	NULL
proteins	NULL
is	NULL
achieved	NULL
through	NULL
activation	NULL
of	NULL
signaling	NULL
pathways	NULL
that	NULL
produce	NULL
a	NULL
rise	NULL
in	NULL
intracellular	NULL
free	NULL
calcium	NULL
levels	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
concentrations	NULL
induces	NULL
activation	NULL
of	NULL
the	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
which	NULL
dephosphory-	NULL
lates	NULL
NFAT	NULL
proteins	NULL
(	NULL
Loh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996b	NULL
;	NULL
Shibasaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

This	NULL
process	NULL
of	NULL
calcium	NULL
mobilization	NULL
and	NULL
calcineurin	NULL
activation	NULL
is	NULL
triggered	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
by	NULL
engagement	NULL
of	NULL
surface	NULL
receptors	NULL
such	NULL
as	NULL
the	NULL
antigen	NULL
receptor	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
TCR	NULL
and	NULL
BCR	NULL
)	NULL
,	NULL
the	NULL
Fey	NULL
receptor	NULL
in	NULL
macrophages	NULL
and	NULL
NK	NULL
cells	NULL
and	NULL
the	NULL
Fes	NULL
receptor	NULL
in	NULL
mast	NULL
cells	NULL
and	NULL
basophils	NULL
(	NULL
reviewed	NULL
in	NULL
Kiani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
constitutively	NULL
active	NULL
intracellular	NULL
kinases	NULL
that	NULL
rephosphorylate	NULL
and	NULL
inactivate	NULL
NFAT	NULL
,	NULL
calcineurin	NULL
is	NULL
continuously	NULL
needed	NULL
to	NULL
maintain	NULL
NFAT	NULL
proteins	NULL
in	NULL
an	NULL
active	NULL
state	NULL
,	NULL
and	NULL
both	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFAT	NULL
and	NULL
its	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
are	NULL
reversed	NULL
by	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
calcineurin	NULL
inhibitors	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
(	NULL
Loh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Shibasaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Timmerman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
NFAT	NULL
activation	NULL
occurs	NULL
optimally	NULL
under	NULL
conditions	NULL
of	NULL
capacitative	NULL
calcium	NULL
entry	NULL
and	NULL
low	NULL
sustained	NULL
increases	NULL
of	NULL
intracellular	NULL
calcium	NULL
,	NULL
while	NULL
large	NULL
transient	NULL
peaks	NULL
of	NULL
calcium	NULL
entry	NULL
,	NULL
that	NULL
activate	NULL
other	NULL
signaling	NULL
intermediates	NULL
and	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
JNK	NULL
and	NULL
NF-xB	NULL
,	NULL
do	NULL
not	NULL
induce	NULL
effective	NULL
(	NULL
ie	NULL
.	NULL

sustained	NULL
)	NULL
nuclear	NULL
translocation	NULL
and	NULL
activation	NULL
of	NULL
NFAT	NULL
proteins	NULL
(	NULL
Dolmetsch	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
capacitative	NULL
calcium	NULL
entry	NULL
is	NULL
demonstrated	NULL
by	NULL
the	NULL
severe	NULL
combined	NULL
immunodefi-ciency	NULL
phenotype	NULL
of	NULL
patients	NULL
with	NULL
primary	NULL
impairments	NULL
of	NULL
capacitative	NULL
calcium	NULL
entry	NULL
,	NULL
who	NULL
exhibit	NULL
severe	NULL
defects	NULL
in	NULL
NFAT	NULL
activation	NULL
and	NULL
production	NULL
of	NULL
multiple	NULL
cytokines	NULL
(	NULL
Feske	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Fischer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
mechanism	NULL
,	NULL
therefore	NULL
,	NULL
represents	NULL
a	NULL
first	NULL
level	NULL
of	NULL
signaling	NULL
specificity	NULL
,	NULL
in	NULL
that	NULL
it	NULL
facilitates	NULL
specific	NULL
decoding	NULL
of	NULL
the	NULL
information	NULL
contained	NULL
in	NULL
the	NULL
amplitude	NULL
and	NULL
duration	NULL
of	NULL
the	NULL
calcium	NULL
signal	NULL
.	NULL

Calcineurin	NULL
A	NULL
conserved	NULL
motif	NULL
in	NULL
the	NULL
regulatory	NULL
domain	NULL
(	NULL
PxIxIT	NULL
)	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
NFAT	NULL
and	NULL
calcineurin	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
,	NULL
1999	NULL
;	NULL
Garciacozar	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
see	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
surface	NULL
of	NULL
NFAT-calcineurin	NULL
interaction	NULL
may	NULL
be	NULL
more	NULL
extensive	NULL
than	NULL
that	NULL
encompassed	NULL
by	NULL
the	NULL
PxIxIT	NULL
sequence	NULL
alone	NULL
(	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Park	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
PxIxIT	NULL
motif	NULL
is	NULL
SPRIEIT	NULL
in	NULL
NFATI	NULL
and	NULL
NFAT2	NULL
,	NULL
CPSIQIT	NULL
in	NULL
NFAT3	NULL
,	NULL
and	NULL
CPSIRIT	NULL
in	NULL
NFAT4	NULL
;	NULL
i.e	NULL
.	NULL

the	NULL
variable	NULL
residues	NULL
in	NULL
the	NULL
PxIxIT	NULL
motif	NULL
are	NULL
polar	NULL
in	NULL
all	NULL
four	NULL
NFAT	NULL
proteins	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
polar	NULL
residues	NULL
to	NULL
alanine	NULL
in	NULL
NFAT1	NULL
greatly	NULL
decreases	NULL
intereaction	NULL
of	NULL
this	NULL
protein	NULL
with	NULL
calcineurin	NULL
,	NULL
and	NULL
a	NULL
peptide	NULL
spanning	NULL
the	NULL
SPRIEIT	NULL
sequence	NULL
blocks	NULL
the	NULL
interaction	NULL
between	NULL
all	NULL
four	NULL
NFAT	NULL
proteins	NULL
and	NULL
calcineurin	NULL
(	NULL
Aramburu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Garciacozar	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
selection	NULL
of	NULL
a	NULL
high-affinity	NULL
calcineurin-binding	NULL
peptide	NULL
from	NULL
a	NULL
degenerate	NULL
peptide	NULL
library	NULL
bearing	NULL
the	NULL
SPRIEIT	NULL
motif	NULL
led	NULL
to	NULL
isolation	NULL
of	NULL
a	NULL
peptide	NULL
(	NULL
PVIVIT	NULL
)	NULL
in	NULL
which	NULL
the	NULL
polar	NULL
residues	NULL
had	NULL
been	NULL
substituted	NULL
with	NULL
bulky	NULL
B-branched	NULL
non-polar	NULL
resides	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

This	NULL
peptide	NULL
was	NULL
approximately	NULL
30-50-fold	NULL
more	NULL
potent	NULL
than	NULL
the	NULL
SPRIEIT	NULL
peptide	NULL
in	NULL
blocking	NULL
NFAT-calcineurin	NULL
binding	NULL
and	NULL
calcineurin-mediate	NULL
dephosphorylation	NULL
of	NULL
all	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
four	NULL
NFAT	NULL
proteins	NULL
;	NULL
however	NULL
it	NULL
did	NULL
not	NULL
block	NULL
the	NULL
calcineurin	NULL
active	NULL
site	NULL
or	NULL
the	NULL
ability	NULL
of	NULL
calcineurin	NULL
to	NULL
dephosphorylate	NULL
several	NULL
protein	NULL
and	NULL
peptide	NULL
substrates	NULL
other	NULL
than	NULL
NFAT	NULL
.	NULL

When	NULL
expressed	NULL
as	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
in	NULL
cells	NULL
,	NULL
the	NULL
VIVIT	NULL
peptide	NULL
selectively	NULL
blocked	NULL
NFAT	NULL
activation	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
NFAT-dependent	NULL
genes	NULL
,	NULL
without	NULL
blocking	NULL
the	NULL
activation	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
e.g	NULL
.	NULL

NF-xB	NULL
)	NULL
or	NULL
affecting	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
that	NULL
were	NULL
calcineurin-dependent	NULL
but	NULL
not	NULL
dependent	NULL
on	NULL
NFAT	NULL
.	NULL

Finally	NULL
,	NULL
substitution	NULL
of	NULL
the	NULL
VIVIT	NULL
sequence	NULL
into	NULL
wildtype	NULL
NFAT1I	NULL
yielded	NULL
a	NULL
protein	NULL
that	NULL
was	NULL
highly	NULL
sensitive	NULL
to	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
calcineurin	NULL
activity	NULL
found	NULL
in	NULL
resting	NULL
cells	NULL
,	NULL
since	NULL
it	NULL
was	NULL
partially	NULL
dephosphorylated	NULL
and	NULL
activated	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Upon	NULL
targeting	NULL
of	NULL
calcineurin	NULL
to	NULL
the	NULL
regulatory	NULL
domain	NULL
of	NULL
NFAT	NULL
proteins	NULL
,	NULL
the	NULL
phosphatase	NULL
removes	NULL
a	NULL
large	NULL
number	NULL
of	NULL
phosphates	NULL
from	NULL
the	NULL
heavily	NULL
phosphorylated	NULL
regulatory	NULL
domains	NULL
,	NULL
causing	NULL
a	NULL
pronounced	NULL
and	NULL
characteristic	NULL
mobility	NULL
shift	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
SDS	NULL
gels	NULL
.	NULL

Detailed	NULL
analysis	NULL
of	NULL
NFATI	NULL
(	NULL
Okamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
indicates	NULL
that	NULL
14	NULL
phosphoserine	NULL
residues	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
located	NULL
in	NULL
highly	NULL
conserved	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
NFAT	NULL
family	NULL
,	NULL
are	NULL
stoichiome-trically	NULL
phosphorylated	NULL
in	NULL
resting	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
13	NULL
of	NULL
these	NULL
are	NULL
dephosphorylated	NULL
upon	NULL
stimulation	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
conservation	NULL
of	NULL
these	NULL
13	NULL
phosphoserine	NULL
residues	NULL
in	NULL
the	NULL
NFAT	NULL
family	NULL
argues	NULL
strongly	NULL
for	NULL
a	NULL
conserved	NULL
mechanism	NULL
of	NULL
NFAT	NULL
regulation	NULL
by	NULL
dephosphorylation	NULL
and	NULL
rephosphorylation	NULL
.	NULL

Mechanism	NULL
of	NULL
NFAT	NULL
activation	NULL
The	NULL
mechanism	NULL
by	NULL
which	NULL
dephosphorylation	NULL
mediates	NULL
NFAT	NULL
regulation	NULL
has	NULL
been	NULL
elucidated	NULL
by	NULL
detailed	NULL
analysis	NULL
of	NULL
NFATI1	NULL
and	NULL
NFAT2	NULL
(	NULL
Beals	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19972	NULL
;	NULL
Neal	NULL
and	NULL
Clipstone	NULL
,	NULL
2001	NULL
;	NULL
Okamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

In	NULL
NFAT1	NULL
,	NULL
removal	NULL
of	NULL
five	NULL
phosphates	NULL
from	NULL
a	NULL
conserved	NULL
serine-rich	NULL
sequence	NULL
located	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
PxIxIT	NULL
calcineurin-binding	NULL
motif	NULL
exposes	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
in	NULL
the	NULL
regulatory	NULL
domain	NULL
and	NULL
renders	NULL
an	NULL
additional	NULL
eight	NULL
phosphoserine	NULL
residues	NULL
in	NULL
the	NULL
regulatory	NULL
domain	NULL
significantly	NULL
more	NULL
accessbile	NULL
to	NULL
calcineurin	NULL
(	NULL
Okamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Complete	NULL
dephosphorylation	NULL
of	NULL
all	NULL
13	NULL
residues	NULL
further	NULL
results	NULL
in	NULL
masking	NULL
of	NULL
a	NULL
nuclear	NULL
export	NULL
signal	NULL
(	NULL
NES	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
the	NULL
nuclear	NULL
export	NULL
receptor	NULL
Crml1l	NULL
,	NULL
and	NULL
promotes	NULL
the	NULL
full	NULL
translocation	NULL
of	NULL
NFAT1	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

It	NULL
is	NULL
not	NULL
entirely	NULL
clear	NULL
whether	NULL
the	NULL
nuclear	NULL
export	NULL
signal	NULL
is	NULL
intrinsically	NULL
encoded	NULL
in	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
NFAT	NULL
proteins	NULL
,	NULL
since	NULL
the	NULL
NES	NULL
sequence	NULL
identified	NULL
in	NULL
NFAT2	NULL
(	NULL
Klemm	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
is	NULL
not	NULL
fully	NULL
conserved	NULL
in	NULL
other	NULL
family	NULL
members	NULL
,	NULL
or	NULL
whether	NULL
it	NULL
is	NULL
conferred	NULL
by	NULL
NES-bearing	NULL
proteins	NULL
such	NULL
as	NULL
14.3.3	NULL
which	NULL
bind	NULL
to	NULL
phosphorylated	NULL
regions	NULL
of	NULL
NFAT	NULL
(	NULL
Chow	NULL
and	NULL
Davis	NULL
,	NULL
2000	NULL
)	NULL
.	NULL

Nevertheless	NULL
the	NULL
data	NULL
for	NULL
NFAT1	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
full	NULL
dephosphorylation	NULL
promotes	NULL
a	NULL
conformational	NULL
switch	NULL
that	NULL
activates	NULL
multiple	NULL
functions	NULL
of	NULL
NFAT1	NULL
,	NULL
including	NULL
its	NULL
nuclear	NULL
localization	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
transcriptional	NULL
activity	NULL
(	NULL
Okamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Park	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Shaw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

2479	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2480	NULL
Extensive	NULL
dephosphorylation	NULL
is	NULL
also	NULL
necessary	NULL
to	NULL
fully	NULL
activate	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
functions	NULL
of	NULL
NFAT2	NULL
(	NULL
Neal	NULL
and	NULL
Clipstone	NULL
,	NULL
2001	NULL
;	NULL
Porter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
;	NULL
thus	NULL
artificial	NULL
localization	NULL
of	NULL
phosphorylated	NULL
NFAT2	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
not	NULL
likely	NULL
to	NULL
be	NULL
sufficient	NULL
for	NULL
full	NULL
transcriptional	NULL
activity	NULL
as	NULL
suggested	NULL
by	NULL
one	NULL
report	NULL
(	NULL
Timmerman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Transcription	NULL
mediated	NULL
by	NULL
nuclear	NULL
NFAT4	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
involve	NULL
extensive	NULL
dephosphorylation	NULL
of	NULL
its	NULL
regulatory	NULL
domain	NULL
.	NULL

Although	NULL
one	NULL
report	NULL
suggested	NULL
that	NULL
phosphatase-dead	NULL
calcineurin	NULL
activated	NULL
NFAT4	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
nuclear	NULL
export	NULL
signal	NULL
and	NULL
competing	NULL
away	NULL
the	NULL
nuclear	NULL
export	NULL
factor	NULL
Crm1	NULL
,	NULL
thus	NULL
interfering	NULL
with	NULL
futile	NULL
shuttling	NULL
of	NULL
NFAT4	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
the	NULL
dominant-negative	NULL
calcineurin	NULL
used	NULL
in	NULL
this	NULL
study	NULL
retained	NULL
~10	NULL
%	NULL
of	NULL
wildtype	NULL
phosphatase	NULL
activity	NULL
(	NULL
Zhu	NULL
and	NULL
McKeon	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

Thus	NULL
taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
plausible	NULL
hypothesis	NULL
that	NULL
dephosphorylation	NULL
plays	NULL
a	NULL
conserved	NULL
role	NULL
in	NULL
activating	NULL
all	NULL
four	NULL
calcinuerin-regulated	NULL
NFAT	NULL
proteins	NULL
at	NULL
multiple	NULL
levels	NULL
including	NULL
localization	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
optimal	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
optimal	NULL
transcriptional	NULL
activity	NULL
.	NULL

Constitutive	NULL
kinases	NULL
that	NULL
oppose	NULL
calcineurin	NULL
and	NULL
inactivate	NULL
NFAT	NULL
There	NULL
are	NULL
conflicting	NULL
data	NULL
about	NULL
which	NULL
kinases	NULL
oppose	NULL
calcineurin	NULL
activity	NULL
to	NULL
rephosphorylate	NULL
and	NULL
therefore	NULL
inactivate	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
.	NULL

The	NULL
expectation	NULL
is	NULL
that	NULL
such	NULL
kinases	NULL
would	NULL
be	NULL
constitutively	NULL
active	NULL
,	NULL
since	NULL
they	NULL
are	NULL
required	NULL
to	NULL
maintain	NULL
NFAT	NULL
in	NULL
its	NULL
phosphorylated	NULL
state	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
one	NULL
would	NULL
expect	NULL
that	NULL
such	NULL
constitutive	NULL
NFAT	NULL
kinases	NULL
would	NULL
phosphorylate	NULL
exactly	NULL
those	NULL
residues	NULL
known	NULL
to	NULL
be	NULL
dephosphorylated	NULL
by	NULL
calcineurin	NULL
following	NULL
cell	NULL
activation	NULL
;	NULL
based	NULL
on	NULL
the	NULL
findings	NULL
with	NULL
NFATI	NULL
discussed	NULL
above	NULL
,	NULL
these	NULL
residues	NULL
are	NULL
conserved	NULL
in	NULL
all	NULL
four	NULL
calcineurin-regulated	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
.	NULL

However	NULL
this	NULL
criterion	NULL
is	NULL
met	NULL
only	NULL
by	NULL
GSK3	NULL
,	NULL
which	NULL
phosphorylates	NULL
the	NULL
conserved	NULL
SPxx	NULL
repeat	NULL
motifs	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
domains	NULL
of	NULL
all	NULL
four	NULL
calcineurin-regulated	NULL
NFAT	NULL
proteins	NULL
including	NULL
NFAT2	NULL
(	NULL
Beals	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997b	NULL
)	NULL
and	NULL
NFAT3	NULL
(	NULL
Graef	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

These	NULL
motifs	NULL
are	NULL
known	NULL
targets	NULL
for	NULL
dephosphorylation	NULL
by	NULL
calcineurin	NULL
(	NULL
Okamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Another	NULL
constitutive	NULL
kinase	NULL
,	NULL
casein	NULL
kinase	NULL
1	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
phosphorylate	NULL
residues	NULL
in	NULL
the	NULL
regulatory	NULL
domain	NULL
of	NULL
NFAT4	NULL
that	NULL
are	NULL
not	NULL
fully	NULL
conserved	NULL
in	NULL
other	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
(	NULL
Zhu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Cross-talk	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
signaling	NULL
pathways	NULL
:	NULL
NFAT	NULL
regulation	NULL
by	NULL
MAP	NULL
kinases	NULL
and	NULL
other	NULL
mitogen-stimulated	NULL
kinases	NULL
Although	NULL
the	NULL
major	NULL
pathways	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
are	NULL
distinct	NULL
,	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
cross-talk	NULL
may	NULL
occur	NULL
.	NULL

As	NULL
reviewed	NULL
elsewhere	NULL
in	NULL
this	NULL
issue	NULL
,	NULL
AP-1	NULL
activation	NULL
is	NULL
regulated	NULL
at	NULL
multiple	NULL
levels	NULL
by	NULL
activation	NULL
of	NULL
MAP	NULL
kinases	NULL
.	NULL

MAP	NULL
kinases	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
regulating	NULL
NFAT	NULL
activation	NULL
,	NULL
although	NULL
the	NULL
data	NULL
(	NULL
which	NULL
are	NULL
often	NULL
based	NULL
on	NULL
NFAT	NULL
and	NULL
Oncogene	NULL
MAP	NULL
kinase	NULL
overexpression	NULL
)	NULL
tend	NULL
to	NULL
be	NULL
contradictory	NULL
and	NULL
are	NULL
not	NULL
always	NULL
internally	NULL
consistent	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
p38	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
phosphorylate	NULL
and	NULL
prevent	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
NFAT1	NULL
(	NULL
del	NULL
Arco	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Porter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
,	NULL
and	NULL
p38	NULL
and	NULL
ERK	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
phosphorylate	NULL
and	NULL
deactivate	NULL
NFAT2	NULL
(	NULL
Porter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
,	NULL
but	NULL
the	NULL
target	NULL
residues	NULL
for	NULL
these	NULL
kinases	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
.	NULL

Likewise	NULL
JNK2	NULL
was	NULL
reported	NULL
to	NULL
phosphorylate	NULL
NFAT4	NULL
and	NULL
control	NULL
its	NULL
cellular	NULL
distribution	NULL
(	NULL
Chow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
although	NULL
this	NULL
finding	NULL
was	NULL
directly	NULL
contradicted	NULL
by	NULL
another	NULL
report	NULL
(	NULL
Zhu	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
JNK	NULL
1	NULL
phosphorylates	NULL
specific	NULL
residues	NULL
in	NULL
the	NULL
PxIxIT	NULL
calcineurin	NULL
targeting	NULL
motif	NULL
of	NULL
NFAT2	NULL
,	NULL
thus	NULL
inhibiting	NULL
the	NULL
NFAT2-calcineurin	NULL
interaction	NULL
(	NULL
Chow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
;	NULL
however	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
NFAT1	NULL
is	NULL
not	NULL
phosphorylated	NULL
in	NULL
stimulated	NULL
cells	NULL
(	NULL
Okamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
this	NULL
region	NULL
is	NULL
selectively	NULL
accessible	NULL
in	NULL
NFAT2	NULL
or	NULL
that	NULL
this	NULL
method	NULL
of	NULL
regulation	NULL
might	NULL
not	NULL
play	NULL
a	NULL
major	NULL
role	NULL
at	NULL
endogenous	NULL
levels	NULL
of	NULL
NFAT	NULL
and	NULL
JNK	NULL
expression	NULL
.	NULL

Nevertheless	NULL
,	NULL
T	NULL
cells	NULL
from	NULL
JNK1I~-~	NULL
mice	NULL
show	NULL
increased	NULL
nuclear	NULL
localization	NULL
of	NULL
NFAT2	NULL
but	NULL
not	NULL
NFATI	NULL
,	NULL
suggesting	NULL
that	NULL
JNK	NULL
directly	NULL
or	NULL
indirectly	NULL
suppresses	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
NFAT	NULL
family	NULL
member	NULL
(	NULL
Dong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
finding	NULL
T	NULL
cells	NULL
engineered	NULL
to	NULL
lack	NULL
all	NULL
JNK	NULL
activity	NULL
show	NULL
increased	NULL
rather	NULL
than	NULL
decreased	NULL
production	NULL
of	NULL
IL-2	NULL
(	NULL
Dong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
point	NULL
is	NULL
that	NULL
JNK	NULL
resembles	NULL
NFAT	NULL
proteins	NULL
in	NULL
being	NULL
activated	NULL
by	NULL
increased	NULL
intracellular	NULL
calcium	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
intracellular	NULL
calcium	NULL
oscillations	NULL
needed	NULL
for	NULL
optimal	NULL
JNK	NULL
activation	NULL
appear	NULL
to	NULL
be	NULL
different	NULL
from	NULL
those	NULL
required	NULL
for	NULL
optimal	NULL
NFAT	NULL
activation	NULL
(	NULL
high	NULL
transient	NULL
calcium	NULL
spikes	NULL
for	NULL
optimal	NULL
JNK	NULL
activation	NULL
,	NULL
compared	NULL
to	NULL
low	NULL
sustained	NULL
increases	NULL
in	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
levels	NULL
for	NULL
optimal	NULL
NFAT	NULL
activation	NULL
)	NULL
(	NULL
Dolmetsch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Werlen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
calcium	NULL
requirement	NULL
for	NULL
JNK	NULL
activation	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
calcineurin	NULL
,	NULL
as	NULL
it	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
calcineurin	NULL
inhibitor	NULL
cyclosporin	NULL
A	NULL
(	NULL
Dolmetsch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Werlen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

A	NULL
new	NULL
phosphorylation	NULL
site	NULL
that	NULL
seems	NULL
to	NULL
be	NULL
important	NULL
for	NULL
NFAT	NULL
activity	NULL
has	NULL
been	NULL
described	NULL
in	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
NFAT1	NULL
(	NULL
Garcia-Rodri-guez	NULL
and	NULL
Rao	NULL
,	NULL
2000	NULL
;	NULL
Okamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

This	NULL
site	NULL
is	NULL
phosphorylated	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
alone	NULL
.	NULL

The	NULL
kinase	NULL
that	NULL
mediates	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
site	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
but	NULL
clearly	NULL
responds	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
and	NULL
not	NULL
to	NULL
the	NULL
classical	NULL
calcium	NULL
signals	NULL
that	NULL
activate	NULL
NFAT	NULL
.	NULL

Signaling	NULL
pathways	NULL
that	NULL
may	NULL
repress	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
Control	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interactions	NULL
may	NULL
also	NULL
be	NULL
achieved	NULL
by	NULL
specific	NULL
repressor	NULL
proteins	NULL
that	NULL
target	NULL
this	NULL
interaction	NULL
and	NULL
can	NULL
control	NULL
their	NULL
activity	NULL
.	NULL

Thus	NULL
ICER	NULL
,	NULL
a	NULL
cAMP-inducible	NULL
transcriptional	NULL
repressor	NULL
,	NULL
binds	NULL
specifically	NULL
to	NULL
NFAT	NULL
:	NULL
AP-1	NULL
composite	NULL
sites	NULL
and	NULL
may	NULL
form	NULL
inactive	NULL
complexes	NULL
with	NULL
NFAT	NULL
(	NULL
Bodor	NULL
and	NULL
Habener	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Once	NULL
bound	NULL
to	NULL
DNA	NULL
,	NULL
ICER	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
that	NULL
controls	NULL
expression	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
IL-2	NULL
and	NULL
IL-4	NULL
by	NULL
targeting	NULL
and	NULL
inhibiting	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
mechanism	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
repressed	NULL
by	NULL
p21°N	NULL
``	NULL
``	NULL
,	NULL
a	NULL
bZIP	NULL
protein	NULL
that	NULL
forms	NULL
complexes	NULL
with	NULL
NFAT	NULL
and	NULL
Jun	NULL
on	NULL
composite	NULL
DNA	NULL
elements	NULL
and	NULL
prevents	NULL
Fos	NULL
from	NULL
being	NULL
incorporated	NULL
into	NULL
the	NULL
ternary	NULL
complex	NULL
(	NULL
Iacobelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

p21°N	NULL
``	NULL
*	NULL
also	NULL
heterodimerizes	NULL
with	NULL
Jun	NULL
and	NULL
inhibits	NULL
Jun	NULL
transcriptional	NULL
activity	NULL
.	NULL

HPK1	NULL
,	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
kinase	NULL
family	NULL
,	NULL
has	NULL
also	NULL
been	NULL
identified	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
Jun	NULL
activation	NULL
during	NULL
TCR	NULL
stimulation	NULL
(	NULL
Liou	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
inhibitors	NULL
might	NULL
regulate	NULL
one	NULL
or	NULL
more	NULL
distinct	NULL
cellular	NULL
processes	NULL
,	NULL
including	NULL
productive	NULL
immune	NULL
response	NULL
,	NULL
apoptosis	NULL
or	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
differentiation	NULL
,	NULL
by	NULL
targeting	NULL
and	NULL
inhibiting	NULL
cooperative	NULL
NFAT	NULL
:	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

NFAT-dependent	NULL
gene	NULL
transcription	NULL
Diversity	NULL
of	NULL
transcriptionally-active	NULL
complexes	NULL
containing	NULL
NFAT	NULL
Cooperative	NULL
complexes	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
The	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
proteins	NULL
of	NULL
the	NULL
Jun	NULL
(	NULL
cJun	NULL
,	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
JunB	NULL
and	NULL
JunD	NULL
)	NULL
and	NULL
Fos	NULL
(	NULL
cFos	NULL
,	NULL
FosB	NULL
,	NULL
Fral	NULL
and	NULL
Fra2	NULL
)	NULL
families	NULL
are	NULL
AP-1	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
as	NULL
homo-	NULL
or	NULL
heterodimers	NULL
to	NULL
AP-1	NULL
regulatory	NULL
elements	NULL
present	NULL
in	NULL
many	NULL
genes	NULL
.	NULL

As	NULL
reviewed	NULL
elsewhere	NULL
in	NULL
this	NULL
issue	NULL
(	NULL
see	NULL
review	NULL
by	NULL
Chinenov	NULL
and	NULL
Kerppola	NULL
in	NULL
this	NULL
issue	NULL
)	NULL
,	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
bind	NULL
DNA	NULL
through	NULL
their	NULL
conserved	NULL
basic	NULL
region	NULL
and	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
through	NULL
their	NULL
leucine	NULL
zipper	NULL
domains	NULL
(	NULL
Glover	NULL
and	NULL
Harrison	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Cooperation	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
the	NULL
promoter/	NULL
enhancer	NULL
region	NULL
of	NULL
several	NULL
genes	NULL
in	NULL
immune	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
in	NULL
this	NULL
issue	NULL
(	NULL
see	NULL
review	NULL
by	NULL
Chinenov	NULL
and	NULL
Kerppola	NULL
in	NULL
this	NULL
issue	NULL
)	NULL
and	NULL
elsewhere	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
composite	NULL
binding	NULL
sites	NULL
has	NULL
been	NULL
observed	NULL
,	NULL
and	NULL
comparable	NULL
degrees	NULL
of	NULL
cooperativity	NULL
appear	NULL
to	NULL
be	NULL
achieved	NULL
in	NULL
vivo	NULL
by	NULL
pairing	NULL
weak	NULL
NFAT	NULL
sites	NULL
with	NULL
moderately	NULL
strong	NULL
AP-1	NULL
sites	NULL
(	NULL
as	NULL
in	NULL
the	NULL
GM330	NULL
element	NULL
of	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
and	NULL
the	NULL
ARRE-1	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
)	NULL
,	NULL
moderately	NULL
strong	NULL
NFAT	NULL
sites	NULL
with	NULL
weak	NULL
AP-1	NULL
sites	NULL
(	NULL
as	NULL
in	NULL
the	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
)	NULL
,	NULL
or	NULL
weak	NULL
AP-1	NULL
sites	NULL
with	NULL
weak	NULL
NFAT	NULL
sites	NULL
(	NULL
as	NULL
in	NULL
the	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
)	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
to	NULL
their	NULL
individual	NULL
binding	NULL
sites	NULL
in	NULL
these	NULL
composite	NULL
elements	NULL
is	NULL
characterized	NULL
by	NULL
relatively	NULL
high	NULL
dissociation	NULL
rates	NULL
,	NULL
but	NULL
a	NULL
strong	NULL
cooperative	NULL
complex	NULL
with	NULL
greatly	NULL
increased	NULL
stability	NULL
is	NULL
formed	NULL
when	NULL
all	NULL
three	NULL
NFAT	NULL
Binding	NULL
Sites	NULL
I	NULL
.	NULL

Composite	NULL
NFAT/AP-1	NULL
sites	NULL
IL-2	NULL
promoter	NULL
(	NULL
murine	NULL
distal	NULL
ARRE-2	NULL
)	NULL
IL-2	NULL
promoter	NULL
(	NULL
human	NULL
distal	NULL
ARRE-2	NULL
)	NULL
GM-CSF	NULL
enhancer	NULL
IL-2	NULL
promoter	NULL
(	NULL
murine	NULL
proximal	NULL
ARRE-1	NULL
)	NULL
II	NULL
.	NULL

NF-xB-like	NULL
sites	NULL
NFAT/NF-	NULL
«	NULL
B	NULL
.	NULL

.	NULL

|	NULL
GGAGAAACCCJA	NULL
[	NULL
TGAGCTCA	NULL
]	NULL
.	NULL

.	NULL

TNFa	NULL
promoter	NULL
x3	NULL
site	NULL
NFAT	NULL
AP-1	NULL
NFAT	NULL
AP-1	NULL
NFAT	NULL
AP-1	NULL
«	NULL
|GGAGCCCCJ|TGAGTCA	NULL
)	NULL
.	NULL

.	NULL

NFAT	NULL
AP-1	NULL
Oct	NULL
«	NULL
TGAAAATAI	NULL
GTGTAA	NULL
[	NULL
TA	NULL
fGTAAAAC	NULL
]	NULL
.	NULL

Jun/ATF2	NULL
NFAT/ANF-	NULL
«	NULL
B	NULL
Sp1	NULL
HIV-1	NULL
LTR	NULL
.	NULL

.	NULL

aa|acagacataacc	NULL
}	NULL
.	NULL

.	NULL

III	NULL
.	NULL

NFAT	NULL
-	NULL
GATA	NULL
sites	NULL
NFAT	NULL
GATA	NULL
GATA	NULL
IL-4	NULL
enhancer	NULL
(	NULL
murine	NULL
)	NULL
«	NULL
.	NULL

|GGAACCAAGGCATCAAC|AGATAACTAGATAA	NULL
)	NULL
..	NULL
NFAT	NULL
GATA	NULL
IL-5	NULL
promoter	NULL
(	NULL
murine	NULL
)	NULL
``	NULL
.	NULL

.	NULL

GGAAATGA	NULL
)	NULL
ATAATTGCTAACAATC|AGATAG	NULL
]	NULL
..	NULL
2481	NULL
Figure	NULL
2	NULL
NFAT	NULL
binding	NULL
sites	NULL
.	NULL

Representative	NULL
examples	NULL
of	NULL
the	NULL
different	NULL
groups	NULL
of	NULL
NFAT	NULL
binding	NULL
sites	NULL
discussed	NULL
in	NULL
the	NULL
text	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
core	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
is	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

``	NULL
Sequence	NULL
of	NULL
the	NULL
murine	NULL
IL-5	NULL
promoter	NULL
is	NULL
from	NULL
the	NULL
non-coding	NULL
strand	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2482	NULL
proteins	NULL
bind	NULL
the	NULL
composite	NULL
DNA	NULL
site	NULL
(	NULL
Chen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
;	NULL
Peterson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
protein-protein	NULL
contacts	NULL
involve	NULL
an	NULL
extended	NULL
network	NULL
of	NULL
backbone	NULL
and	NULL
side-chain	NULL
contacts	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
they	NULL
are	NULL
not	NULL
strong	NULL
enough	NULL
to	NULL
stabilize	NULL
the	NULL
NFAT	NULL
:	NULL
AP-1	NULL
complex	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
structurally	NULL
best-characterized	NULL
example	NULL
of	NULL
cooperative	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
occurs	NULL
at	NULL
the	NULL
composite	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
NFAT	NULL
(	NULL
GGAAAA	NULL
)	NULL
and	NULL
a	NULL
weak	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
TGTTTCA	NULL
)	NULL
separated	NULL
by	NULL
two	NULL
base	NULL
pairs	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
the	NULL
intervening	NULL
bases	NULL
are	NULL
TT	NULL
,	NULL
and	NULL
the	NULL
site	NULL
supports	NULL
weak	NULL
binding	NULL
of	NULL
NFAT	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
AP-1	NULL
;	NULL
in	NULL
contrast	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
AC	NULL
intervening	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
element	NULL
greatly	NULL
reduces	NULL
the	NULL
independent	NULL
binding	NULL
of	NULL
NFAT	NULL
(	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
NFAT	NULL
and	NULL
the	NULL
bZIP	NULL
regions	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
achieve	NULL
cooperative	NULL
association	NULL
of	NULL
the	NULL
ternary	NULL
NFAT	NULL
:	NULL
AP-1	NULL
complex	NULL
on	NULL
the	NULL
ARRE-2	NULL
site	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
is	NULL
sustained	NULL
by	NULL
an	NULL
extended	NULL
contact	NULL
surface	NULL
between	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
the	NULL
NFAT	NULL
Rel	NULL
homology	NULL
region	NULL
and	NULL
the	NULL
leucine	NULL
zipper	NULL
regions	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
,	NULL
and	NULL
facilitated	NULL
by	NULL
the	NULL
bending	NULL
of	NULL
both	NULL
the	NULL
AP-1	NULL
heterodimer	NULL
and	NULL
the	NULL
DNA	NULL
towards	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Diebold	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
(	NULL
see	NULL
review	NULL
by	NULL
Chinenov	NULL
and	NULL
Kerppola	NULL
in	NULL
this	NULL
issue	NULL
)	NULL
.	NULL

Although	NULL
Fos-Jun	NULL
dimers	NULL
can	NULL
normally	NULL
bind	NULL
in	NULL
both	NULL
possible	NULL
orientations	NULL
on	NULL
_	NULL
AP-l1	NULL
_	NULL
sites	NULL
,	NULL
the	NULL
cooperative	NULL
complex	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
has	NULL
a	NULL
very	NULL
specific	NULL
orientation	NULL
,	NULL
in	NULL
which	NULL
Jun	NULL
binds	NULL
the	NULL
AP-1	NULL
half-site	NULL
closer	NULL
to	NULL
NFAT	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
1995	NULL
;	NULL
Diebold	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
see	NULL
review	NULL
by	NULL
Chinenov	NULL
and	NULL
Kerppola	NULL
in	NULL
this	NULL
issue	NULL
)	NULL
.	NULL

Although	NULL
most	NULL
contacts	NULL
involve	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
the	NULL
NFAT	NULL
Rel	NULL
homology	NULL
region	NULL
the	NULL
carboxy-terminal	NULL
domain	NULL
of	NULL
this	NULL
region	NULL
makes	NULL
some	NULL
contacts	NULL
with	NULL
Fos	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Two	NULL
major	NULL
foci	NULL
in	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
the	NULL
NFAT	NULL
Rel-homology	NULL
region	NULL
are	NULL
responsible	NULL
for	NULL
holding	NULL
the	NULL
ternary	NULL
complex	NULL
together	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

The	NULL
EF	NULL
loop	NULL
in	NULL
the	NULL
NFAT	NULL
Rel-homology	NULL
region	NULL
,	NULL
supported	NULL
by	NULL
a	NULL
small	NULL
hydrophobic	NULL
patch	NULL
centered	NULL
on	NULL
Phe573	NULL
in	NULL
NFAT1I	NULL
,	NULL
contacts	NULL
the	NULL
fork	NULL
region	NULL
of	NULL
Jun	NULL
close	NULL
to	NULL
the	NULL
DNA	NULL
surface	NULL
,	NULL
while	NULL
the	NULL
CX	NULL
loop	NULL
contacts	NULL
Fos	NULL
in	NULL
successive	NULL
layers	NULL
along	NULL
the	NULL
zipper	NULL
helix	NULL
.	NULL

The	NULL
residues	NULL
of	NULL
NFAT	NULL
proteins	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
making	NULL
contacts	NULL
with	NULL
DNA	NULL
and	NULL
with	NULL
Jun	NULL
are	NULL
very	NULL
conserved	NULL
in	NULL
the	NULL
four	NULL
classical	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
while	NULL
the	NULL
residues	NULL
involved	NULL
in	NULL
Fos	NULL
contact	NULL
are	NULL
more	NULL
variable	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
protein-protein	NULL
contacts	NULL
mediated	NULL
by	NULL
the	NULL
E	NULL
'	NULL
F	NULL
and	NULL
CX	NULL
loops	NULL
of	NULL
the	NULL
NFAT	NULL
Rel-homology	NULL
region	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
NFAT	NULL
with	NULL
AP-1	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
despite	NULL
the	NULL
extended	NULL
network	NULL
of	NULL
contacts	NULL
,	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
can	NULL
be	NULL
completely	NULL
disrupted	NULL
by	NULL
making	NULL
limited	NULL
substitutions	NULL
in	NULL
the	NULL
NFAT-Fos-Jun	NULL
interface	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
substitutions	NULL
Oncogene	NULL
of	NULL
Arg468	NULL
and	NULL
Ile469	NULL
on	NULL
the	NULL
CX	NULL
loop	NULL
and	NULL
Thr535	NULL
in	NULL
the	NULL
E	NULL
'	NULL
F	NULL
loop	NULL
of	NULL
NFATI1	NULL
with	NULL
alanine	NULL
,	NULL
alanine	NULL
and	NULL
glycine	NULL
respectively	NULL
eliminate	NULL
all	NULL
cooperative	NULL
interactions	NULL
between	NULL
NFAT	NULL
and	NULL
Fos/Jun	NULL
or	NULL
Jun-Jun	NULL
dimers	NULL
,	NULL
without	NULL
altering	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Similar	NULL
results	NULL
are	NULL
obtained	NULL
when	NULL
Phe473	NULL
is	NULL
mutated	NULL
to	NULL
Ala	NULL
,	NULL
NFAT-DBD-C	NULL
.	NULL

ﬁﬁﬂ	NULL
'	NULL
u	NULL
.	NULL

B	NULL
,	NULL
NFAT-DBD-N	NULL
f	NULL
”	NULL
if	NULL
“	NULL
W	NULL
#	NULL
e	NULL
b	NULL
el	NULL
;	NULL
@	NULL
R	NULL
Wf	NULL
Ls	NULL
\_	NULL
``	NULL
Figure	NULL
3	NULL
Representation	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
formed	NULL
on	NULL
the	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
NFAT	NULL
,	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

The	NULL
colors	NULL
on	NULL
the	NULL
surface	NULL
representation	NULL
of	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
domain	NULL
represent	NULL
electrostatic	NULL
potential	NULL
(	NULL
blue	NULL
,	NULL
positive	NULL
;	NULL
red	NULL
,	NULL
negative	NULL
)	NULL
.	NULL

NFAT-DBD-N	NULL
:	NULL
amino-terminal	NULL
domain	NULL
of	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

NFAT-DBD-C	NULL
:	NULL
carboxy-terminal	NULL
domain	NULL
of	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
domain	NULL
Figure	NULL
4	NULL
The	NULL
NFAT/AP-1	NULL
interface	NULL
.	NULL

Side	NULL
chains	NULL
of	NULL
critical	NULL
residues	NULL
maintaining	NULL
the	NULL
interaction	NULL
between	NULL
E	NULL
'	NULL
F	NULL
and	NULL
CX	NULL
loops	NULL
of	NULL
NFAT	NULL
(	NULL
in	NULL
yellow	NULL
)	NULL
and	NULL
Fos	NULL
(	NULL
in	NULL
red	NULL
)	NULL
/	NULL
Jun	NULL
(	NULL
in	NULL
blue	NULL
)	NULL
are	NULL
highlighted	NULL
thus	NULL
disrupting	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
E	NULL
'	NULL
F	NULL
loop	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
NFAT	NULL
dimers	NULL
to	NULL
Rel/NF-xB-like	NULL
binding	NULL
sites	NULL
In	NULL
addition	NULL
to	NULL
forming	NULL
composite	NULL
complexes	NULL
with	NULL
AP-1	NULL
dimers	NULL
,	NULL
the	NULL
calcium-regulated	NULL
NFAT	NULL
proteins	NULL
can	NULL
bind	NULL
as	NULL
dimers	NULL
to	NULL
Rel/NF-xB-like	NULL
elements	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
certain	NULL
NFAT	NULL
target	NULL
genes	NULL
(	NULL
Kinoshita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Macian	NULL
and	NULL
Rao	NULL
,	NULL
1999	NULL
;	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

These	NULL
dimers	NULL
are	NULL
weak	NULL
and	NULL
non-cooperative	NULL
,	NULL
and	NULL
form	NULL
only	NULL
on	NULL
DNA	NULL
;	NULL
in	NULL
solution	NULL
,	NULL
the	NULL
NFAT	NULL
proteins	NULL
are	NULL
strictly	NULL
monomeric	NULL
except	NULL
at	NULL
unphysiologically	NULL
high	NULL
concentrations	NULL
.	NULL

NFATS5	NULL
represents	NULL
a	NULL
special	NULL
case	NULL
,	NULL
since	NULL
this	NULL
protein	NULL
is	NULL
an	NULL
obligatory	NULL
dimer	NULL
both	NULL
in	NULL
solution	NULL
and	NULL
in	NULL
its	NULL
DNA-bound	NULL
form	NULL
;	NULL
as	NULL
with	NULL
Rel/	NULL
NF-xB	NULL
proteins	NULL
,	NULL
dimerization	NULL
is	NULL
necessary	NULL
for	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
function	NULL
(	NULL
discussed	NULL
below	NULL
)	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999a	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
ability	NULL
of	NULL
NFAT	NULL
proteins	NULL
to	NULL
form	NULL
dimers	NULL
,	NULL
there	NULL
are	NULL
no	NULL
reports	NULL
of	NULL
cross-dimerization	NULL
between	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
NF-xB/	NULL
Rel	NULL
families	NULL
.	NULL

Examples	NULL
of	NULL
AP-l-independent	NULL
,	NULL
NF-xB/Rel-like	NULL
binding	NULL
sites	NULL
for	NULL
NFAT	NULL
proteins	NULL
are	NULL
provided	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

A	NULL
good	NULL
example	NULL
is	NULL
the	NULL
k3	NULL
element	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
,	NULL
which	NULL
binds	NULL
NFAT	NULL
dimers	NULL
(	NULL
McCaf-frey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
as	NULL
well	NULL
as	NULL
certain	NULL
Rel-containing	NULL
dimers	NULL
(	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
in	NULL
vitro	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
tandem	NULL
NF-xB	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
which	NULL
are	NULL
clearly	NULL
capable	NULL
of	NULL
binding	NULL
p50/	NULL
RelA	NULL
dimers	NULL
,	NULL
also	NULL
support	NULL
the	NULL
weaker	NULL
binding	NULL
of	NULL
NFAT	NULL
proteins	NULL
(	NULL
Kinoshita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Macian	NULL
and	NULL
Rao	NULL
,	NULL
1999	NULL
;	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
5°	NULL
half-sites	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
NF-xB	NULL
elements	NULL
,	NULL
which	NULL
eliminate	NULL
NF-xB	NULL
binding	NULL
,	NULL
have	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
binding	NULL
of	NULL
NFAT	NULL
proteins	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
NFAT	NULL
dimer	NULL
nucleates	NULL
preferentially	NULL
on	NULL
the	NULL
3	NULL
'	NULL
half-site	NULL
of	NULL
these	NULL
Rel/	NULL
NF-xB-like	NULL
elements	NULL
.	NULL

NFAT	NULL
:	NULL
GATA	NULL
cooperation	NULL
There	NULL
is	NULL
also	NULL
considerable	NULL
evidence	NULL
for	NULL
functional	NULL
cooperation	NULL
between	NULL
NFAT	NULL
and	NULL
GATA	NULL
proteins	NULL
,	NULL
although	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
whether	NULL
this	NULL
is	NULL
due	NULL
to	NULL
a	NULL
physical	NULL
mechanism	NULL
of	NULL
cooperative	NULL
stabilization	NULL
of	NULL
NFAT-GATA	NULL
complexes	NULL
on	NULL
DNA	NULL
.	NULL

NFAT3	NULL
and	NULL
GATA4	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
in	NULL
yeast	NULL
two-hybrid	NULL
assays	NULL
,	NULL
and	NULL
NFAT3-GATAA4	NULL
cooperation	NULL
may	NULL
be	NULL
important	NULL
for	NULL
cardiomyo-cyte	NULL
growth	NULL
and	NULL
cardiac	NULL
hypertrophy	NULL
.	NULL

NFAT2	NULL
and	NULL
GATA2	NULL
are	NULL
co-expressed	NULL
in	NULL
nuclei	NULL
of	NULL
developing	NULL
myoblasts	NULL
differentiating	NULL
in	NULL
response	NULL
to	NULL
IGF-1	NULL
,	NULL
and	NULL
can	NULL
be	NULL
co-immunoprecipitated	NULL
from	NULL
skeletal	NULL
muscle	NULL
extracts	NULL
.	NULL

A	NULL
distal	NULL
enhancer	NULL
in	NULL
the	NULL
IL-4	NULL
gene	NULL
binds	NULL
both	NULL
and	NULL
GATA3	NULL
,	NULL
and	NULL
cooperation	NULL
between	NULL
these	NULL
proteins	NULL
may	NULL
be	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
may	NULL
also	NULL
require	NULL
both	NULL
NFAT	NULL
and	NULL
GATA3	NULL
.	NULL

Thus	NULL
the	NULL
theme	NULL
of	NULL
NFAT-GATA	NULL
cooperation	NULL
is	NULL
observed	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
in	NULL
the	NULL
context	NULL
of	NULL
diverse	NULL
biological	NULL
outcomes	NULL
,	NULL
and	NULL
an	NULL
investigation	NULL
into	NULL
the	NULL
underlying	NULL
mechanism	NULL
will	NULL
be	NULL
of	NULL
considerable	NULL
interest	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
E	NULL
'	NULL
F	NULL
loop	NULL
,	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
which	NULL
mediates	NULL
NFAT	NULL
:	NULL
DNA	NULL
and	NULL
NFAT	NULL
:	NULL
Jun	NULL
contact	NULL
,	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
NFAT	NULL
:	NULL
GATA	NULL
cooperation	NULL
.	NULL

This	NULL
loop	NULL
shows	NULL
structural	NULL
variability	NULL
between	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
Rel	NULL
families	NULL
,	NULL
and	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
cooperative	NULL
interactions	NULL
of	NULL
Rel	NULL
proteins	NULL
with	NULL
different	NULL
biological	NULL
partners	NULL
.	NULL

Genes	NULL
regulated	NULL
by	NULL
NFAT	NULL
in	NULL
cooperation	NULL
with	NULL
AP-1	NULL
NFAT	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
regulating	NULL
transcription	NULL
of	NULL
a	NULL
very	NULL
large	NULL
number	NULL
of	NULL
inducible	NULL
genes	NULL
in	NULL
immune-system	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
include	NULL
the	NULL
IL-2	NULL
gene	NULL
;	NULL
the	NULL
linked	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
genes	NULL
;	NULL
the	NULL
linked	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
genes	NULL
that	NULL
are	NULL
coordinately	NULL
expressed	NULL
by	NULL
differentiated	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
T	NULL
cells	NULL
;	NULL
the	NULL
IFNy	NULL
gene	NULL
encoding	NULL
the	NULL
defining	NULL
cytokine	NULL
expressed	NULL
by	NULL
Thl	NULL
cells	NULL
;	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
TNFa	NULL
;	NULL
the	NULL
genes	NULL
encoding	NULL
the	NULL
cell-surface	NULL
receptors	NULL
CD40L	NULL
,	NULL
FasL	NULL
,	NULL
CD5	NULL
,	NULL
Igx	NULL
,	NULL
and	NULL
CD25	NULL
;	NULL
the	NULL
chemokine	NULL
genes	NULL
IL-8	NULL
and	NULL
MIP-1	NULL
«	NULL
,	NULL
and	NULL
the	NULL
cyclooxygenase	NULL
2	NULL
(	NULL
Cox2	NULL
)	NULL
gene	NULL
.	NULL

The	NULL
many	NULL
ex	NULL
vivo	NULL
studies	NULL
documenting	NULL
this	NULL
point	NULL
have	NULL
been	NULL
validated	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
T	NULL
cells	NULL
lacking	NULL
the	NULL
two	NULL
major	NULL
NFAT	NULL
family	NULL
members	NULL
expressed	NULL
in	NULL
immune-system	NULL
cells	NULL
,	NULL
NFAT1	NULL
and	NULL
NFAT2	NULL
,	NULL
are	NULL
effectively	NULL
incapable	NULL
of	NULL
producing	NULL
many	NULL
of	NULL
these	NULL
inducible	NULL
genes	NULL
(	NULL
Peng	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2001	NULL
)	NULL
.	NULL

In	NULL
other	NULL
cases	NULL
expression	NULL
of	NULL
the	NULL
VIVIT	NULL
peptide	NULL
,	NULL
which	NULL
inhibits	NULL
NFAT	NULL
:	NULL
calcineurin	NULL
binding	NULL
and	NULL
therefore	NULL
NFAT	NULL
activation	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
transcription	NULL
of	NULL
endogenous	NULL
inducible	NULL
genes	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

For	NULL
the	NULL
majority	NULL
of	NULL
these	NULL
genes	NULL
a	NULL
dependence	NULL
on	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
has	NULL
been	NULL
established	NULL
,	NULL
in	NULL
part	NULL
by	NULL
using	NULL
an	NULL
elegant	NULL
strategy	NULL
involving	NULL
use	NULL
of	NULL
a	NULL
mutant	NULL
NFATI	NULL
protein	NULL
that	NULL
can	NULL
not	NULL
cooperate	NULL
with	NULL
AP-1	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

A	NULL
notable	NULL
exception	NULL
is	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
,	NULL
discussed	NULL
in	NULL
the	NULL
following	NULL
section	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
known	NULL
NFAT	NULL
binding	NULL
sites	NULL
in	NULL
these	NULL
genes	NULL
are	NULL
in	NULL
fact	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
DNA	NULL
elements	NULL
,	NULL
which	NULL
as	NULL
discussed	NULL
above	NULL
are	NULL
composed	NULL
of	NULL
an	NULL
NFAT	NULL
site	NULL
whose	NULL
core	NULL
sequence	NULL
(	NULL
GGAAA	NULL
)	NULL
is	NULL
positioned	NULL
~3	NULL
base	NULL
pairs	NULL
from	NULL
the	NULL
start	NULL
of	NULL
an	NULL
often	NULL
weak	NULL
AP-1	NULL
site	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
selected	NULL
NFAT	NULL
:	NULL
AP-1	NULL
target	NULL
genes	NULL
and	NULL
individual	NULL
NFAT	NULL
:	NULL
AP-1	NULL
composite	NULL
elements	NULL
in	NULL
these	NULL
genes	NULL
are	NULL
briefly	NULL
reviewed	NULL
below	NULL
.	NULL

IL-2	NULL
NFAT	NULL
proteins	NULL
are	NULL
necessary	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
as	NULL
inferred	NULL
from	NULL
the	NULL
fact	NULL
that	NULL
IL-2	NULL
expression	NULL
is	NULL
strongly	NULL
inhibited	NULL
by	NULL
the	NULL
VIVIT	NULL
peptide	NULL
(	NULL
Aramburu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
and	NULL
by	NULL
a	NULL
dominant-negative	NULL
fragment	NULL
containing	NULL
the	NULL
calcineurin-binding	NULL
region	NULL
of	NULL
NFAT4	NULL
(	NULL
Chow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
and	NULL
that	NULL
T	NULL
cells	NULL
lacking	NULL
both	NULL
NFATI1	NULL
and	NULL
NFAT2	NULL
do	NULL
not	NULL
produce	NULL
IL-2	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
stimulation	NULL
(	NULL
Peng	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2001	NULL
)	NULL
.	NULL

Cooperation	NULL
of	NULL
NFAT	NULL
with	NULL
AP-1	NULL
is	NULL
required	NULL
for	NULL
IL-2	NULL
gene	NULL
transcription	NULL
,	NULL
as	NULL
apparent	NULL
from	NULL
studies	NULL
using	NULL
a	NULL
mutant	NULL
NFAT1	NULL
protein	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
Fos/Jun	NULL
heterodimers	NULL
(	NULL
Macian	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
contains	NULL
four	NULL
(	NULL
or	NULL
perhaps	NULL
five	NULL
)	NULL
NFAT	NULL
binding	NULL
sites	NULL
,	NULL
of	NULL
which	NULL
two	NULL
(	NULL
or	NULL
three	NULL
)	NULL
are	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
binding	NULL
elements	NULL
(	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
;	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
;	NULL
see	NULL
2483	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2484	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

The	NULL
distal	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
located	NULL
at	NULL
-	NULL
280	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
is	NULL
a	NULL
true	NULL
composite	NULL
element	NULL
,	NULL
since	NULL
simultaneous	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
to	NULL
this	NULL
element	NULL
greatly	NULL
increases	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
.	NULL

The	NULL
proximal	NULL
site	NULL
at	NULL
-135	NULL
bp	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
site	NULL
.	NULL

The	NULL
site	NULL
at	NULL
-90	NULL
bp	NULL
is	NULL
interesting	NULL
because	NULL
it	NULL
contains	NULL
a	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
element	NULL
in	NULL
which	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
GAAA	NULL
)	NULL
is	NULL
very	NULL
weak	NULL
and	NULL
does	NULL
not	NULL
conform	NULL
to	NULL
the	NULL
consensus	NULL
(	NULL
GGAAA	NULL
)	NULL
,	NULL
and	NULL
because	NULL
the	NULL
adjacent	NULL
AP-1	NULL
site	NULL
is	NULL
located	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
an	NULL
Oct	NULL
binding	NULL
site	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

A	NULL
site	NULL
located	NULL
at	NULL
-45	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
high-affinity	NULL
NFAT	NULL
binding	NULL
site	NULL
that	NULL
does	NULL
not	NULL
require	NULL
cooperation	NULL
with	NULL
AP-1	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
the	NULL
characteristics	NULL
of	NULL
a	NULL
dimeric	NULL
NFAT/NF-xB/	NULL
Rel	NULL
site	NULL
;	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
both	NULL
NFAT	NULL
dimers	NULL
and	NULL
NF-xB/	NULL
Rel	NULL
dimers	NULL
and	NULL
to	NULL
function	NULL
cooperatively	NULL
with	NULL
AP-1	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
adjacent	NULL
AP-1	NULL
site	NULL
(	NULL
Himes	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
)	NULL
.	NULL

GM-CSF	NULL
and	NULL
IL-3	NULL
_	NULL
The	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
genes	NULL
are	NULL
closely	NULL
linked	NULL
,	NULL
being	NULL
separated	NULL
by	NULL
only	NULL
10	NULL
kbp	NULL
in	NULL
both	NULL
humans	NULL
and	NULL
mice	NULL
.	NULL

Upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
lies	NULL
an	NULL
enhancer	NULL
element	NULL
that	NULL
controls	NULL
GM-CSF	NULL
expression	NULL
and	NULL
contains	NULL
four	NULL
NFAT	NULL
sites	NULL
,	NULL
three	NULL
of	NULL
which	NULL
support	NULL
cooperative	NULL
binding	NULL
with	NULL
AP-1	NULL
(	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
cell-type	NULL
specificity	NULL
of	NULL
GM-CSF	NULL
expression	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
IL-3	NULL
:	NULL
GM-CSF	NULL
is	NULL
expressed	NULL
by	NULL
lymphocytes	NULL
as	NULL
well	NULL
as	NULL
myeloid	NULL
cells	NULL
,	NULL
while	NULL
IL-3	NULL
is	NULL
exclusively	NULL
expressed	NULL
by	NULL
lymphoid	NULL
cells	NULL
.	NULL

This	NULL
difference	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
IL-3	NULL
gene	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
separate	NULL
upstream	NULL
enhancer	NULL
,	NULL
that	NULL
contains	NULL
NFAT	NULL
:	NULL
Oct	NULL
elements	NULL
rather	NULL
than	NULL
NFAT	NULL
:	NULL
AP-1	NULL
composite	NULL
sites	NULL
(	NULL
Bert	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Cockerill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
;	NULL
Duncliffe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
the	NULL
use	NULL
of	NULL
a	NULL
mutant	NULL
NFAT1	NULL
protein	NULL
incapable	NULL
of	NULL
AP-1	NULL
interaction	NULL
shows	NULL
clearly	NULL
that	NULL
both	NULL
IL-3	NULL
promoter	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
IL-3	NULL
gene	NULL
required	NULL
cooperative	NULL
interactions	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
thus	NULL
placing	NULL
IL-3	NULL
firmly	NULL
in	NULL
the	NULL
category	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1-dependent	NULL
genes	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

IL-4	NULL
,	NULL
IL-5	NULL
and	NULL
IL-13	NULL
These	NULL
three	NULL
cytokines	NULL
are	NULL
signature	NULL
cytokines	NULL
of	NULL
the	NULL
Th2	NULL
lineage	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
produced	NULL
when	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
antigen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
require	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
.	NULL

However	NULL
,	NULL
Th2	NULL
differentiation	NULL
is	NULL
also	NULL
known	NULL
to	NULL
require	NULL
GATA3	NULL
(	NULL
reviewed	NULL
in	NULL
Avni	NULL
and	NULL
Rao	NULL
,	NULL
2000	NULL
)	NULL
and	NULL
it	NULL
is	NULL
plausible	NULL
that	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
these	NULL
genes	NULL
also	NULL
support	NULL
cooperative	NULL
NFAT	NULL
:	NULL
GATA3	NULL
interactions	NULL
.	NULL

IL-4	NULL
.	NULL

At	NULL
least	NULL
five	NULL
different	NULL
NFAT	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
with	NULL
at	NULL
least	NULL
three	NULL
of	NULL
them	NULL
being	NULL
composite	NULL
sites	NULL
binding	NULL
NFAT	NULL
and	NULL
AP-1	NULL
(	NULL
Burke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
;	NULL
Takemoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

A	NULL
distal	NULL
IL-4	NULL
enhancer	NULL
located	NULL
3	NULL
'	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
tandem	NULL
binding	NULL
sites	NULL
for	NULL
NFAT	NULL
and	NULL
GATA	NULL
proteins	NULL
,	NULL
and	NULL
to	NULL
bind	NULL
both	NULL
NFATI	NULL
and	NULL
Oncogene	NULL
GATA3	NULL
in	NULL
chromatin	NULL
immunoprecipitation	NULL
assays	NULL
(	NULL
Agarwal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Hodge	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Cooperation	NULL
between	NULL
NFAT	NULL
and	NULL
other	NULL
proteins	NULL
(	NULL
c-Maf	NULL
,	NULL
NIP45	NULL
)	NULL
on	NULL
the	NULL
IL-4	NULL
promoter	NULL
has	NULL
also	NULL
been	NULL
proposed	NULL
(	NULL
Agarwal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Hodge	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

IL-5	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
reported	NULL
that	NULL
IL-5	NULL
transcription	NULL
is	NULL
NFAT-dependent	NULL
and	NULL
,	NULL
although	NULL
interaction	NULL
with	NULL
other	NULL
factors	NULL
such	NULL
as	NULL
GATA-3	NULL
has	NULL
been	NULL
suggested	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
cooperation	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
on	NULL
putative	NULL
composite	NULL
sites	NULL
on	NULL
the	NULL
IL-5	NULL
promoter	NULL
has	NULL
been	NULL
described	NULL
(	NULL
reviewed	NULL
in	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

IL-13	NULL
.	NULL

While	NULL
the	NULL
IL-13	NULL
promoter	NULL
was	NULL
induced	NULL
in	NULL
an	NULL
AP-1-dependent	NULL
fashion	NULL
by	NULL
a	NULL
mutant	NULL
NFAT	NULL
protein	NULL
incapable	NULL
of	NULL
making	NULL
cooperative	NULL
interactions	NULL
with	NULL
AP-1	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
IL-13	NULL
gene	NULL
required	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
,	NULL
suggesting	NULL
the	NULL
existence	NULL
of	NULL
distal	NULL
regulatory	NULL
regions	NULL
that	NULL
contain	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
sites	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

IFN-y	NULL
This	NULL
cytokine	NULL
defines	NULL
the	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Thl	NULL
)	NULL
lineage	NULL
.	NULL

Its	NULL
NFAT	NULL
dependence	NULL
is	NULL
inferred	NULL
from	NULL
the	NULL
fact	NULL
that	NULL
T	NULL
cells	NULL
lacking	NULL
both	NULL
NFAT1	NULL
and	NULL
NFAT2	NULL
show	NULL
no	NULL
IFN-y	NULL
expression	NULL
(	NULL
Peng	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2001	NULL
)	NULL
.	NULL

Chromatin	NULL
immunoprecipitation	NULL
assays	NULL
confirm	NULL
that	NULL
NFAT1	NULL
binds	NULL
selectively	NULL
in	NULL
vivo	NULL
to	NULL
the	NULL
IFN-y	NULL
promoter	NULL
region	NULL
,	NULL
which	NULL
is	NULL
not	NULL
accessible	NULL
to	NULL
NFAT	NULL
binding	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
Agarwal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Hodge	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
;	NULL
the	NULL
likely	NULL
site	NULL
in	NULL
the	NULL
IFN-y	NULL
promoter	NULL
has	NULL
an	NULL
adjacent	NULL
AP-1	NULL
site	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
support	NULL
cooperative	NULL
interactions	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
(	NULL
reviewed	NULL
in	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
the	NULL
IFN-y	NULL
promoter	NULL
alone	NULL
shows	NULL
weak	NULL
inducibility	NULL
that	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
IFN-y	NULL
producing	NULL
Thl1	NULL
cells	NULL
,	NULL
and	NULL
thus	NULL
distal	NULL
regulatory	NULL
regions	NULL
may	NULL
be	NULL
required	NULL
.	NULL

A	NULL
T-box	NULL
transcription	NULL
factor	NULL
,	NULL
T-Bet	NULL
,	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
Thl	NULL
lineage	NULL
commitment	NULL
and	NULL
IFN-y	NULL
production	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
,	NULL
and	NULL
it	NULL
would	NULL
be	NULL
worthwhile	NULL
to	NULL
investigate	NULL
the	NULL
possibility	NULL
of	NULL
NFAT	NULL
:	NULL
T-Bet	NULL
cooperation	NULL
at	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
IFN-y	NULL
gene	NULL
.	NULL

FasL	NULL
_	NULL
Two	NULL
NFAT	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
in	NULL
the	NULL
Fas	NULL
ligand	NULL
promoter	NULL
(	NULL
Latinis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
FasL	NULL
expression	NULL
is	NULL
induced	NULL
by	NULL
engagement	NULL
of	NULL
both	NULL
TCR	NULL
and	NULL
the	NULL
costimulatory	NULL
receptor	NULL
CD28	NULL
(	NULL
Norian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Full	NULL
stimulation	NULL
of	NULL
the	NULL
FasL	NULL
promoter	NULL
appears	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
cooperation	NULL
of	NULL
calcineurin	NULL
and	NULL
PKCO	NULL
and	NULL
involves	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
(	NULL
Villalba	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Similar	NULL
cooperation	NULL
between	NULL
PKCO	NULL
and	NULL
calcineurin	NULL
is	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
JNK	NULL
and	NULL
activate	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
Werlen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

CD25	NULL
NFAT	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD25	NULL
expression	NULL
(	NULL
Schuh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

NFAT	NULL
and	NULL
NFAT2	NULL
bind	NULL
to	NULL
two	NULL
different	NULL
sites	NULL
within	NULL
the	NULL
CD25	NULL
promoter	NULL
with	NULL
adjacent	NULL
non-consensus	NULL
AP-1	NULL
sites	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
show	NULL
that	NULL
complexes	NULL
that	NULL
bind	NULL
these	NULL
sites	NULL
contain	NULL
NFAT	NULL
and	NULL
AP-1	NULL
.	NULL

Cox2	NULL
The	NULL
promoter	NULL
of	NULL
the	NULL
cyclooxygenase	NULL
2	NULL
(	NULL
Cox2	NULL
)	NULL
gene	NULL
,	NULL
an	NULL
inducible	NULL
early	NULL
response	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
contains	NULL
two	NULL
NFAT	NULL
sites	NULL
,	NULL
one	NULL
of	NULL
which	NULL
resembles	NULL
an	NULL
NFAT	NULL
:	NULL
AP-1	NULL
composite	NULL
site	NULL
(	NULL
Iniguez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
COX-2	NULL
expression	NULL
requires	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
and	NULL
is	NULL
inhibited	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
NFAT	NULL
and	NULL
Jun	NULL
.	NULL

These	NULL
results	NULL
and	NULL
the	NULL
detection	NULL
in	NULL
gel	NULL
shift	NULL
experiments	NULL
of	NULL
complexes	NULL
containing	NULL
NFAT	NULL
and	NULL
AP-1	NULL
suggest	NULL
that	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
regulates	NULL
COX2	NULL
gene	NULL
transcription	NULL
(	NULL
Iniguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Genes	NULL
independent	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
TNFx	NULL
To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
for	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
an	NULL
NFAT	NULL
mutant	NULL
protein	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
and	NULL
Jun/Jun	NULL
dimers	NULL
)	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
whereas	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
was	NULL
essential	NULL
for	NULL
NFAT-dependent	NULL
transcription	NULL
of	NULL
certain	NULL
genes	NULL
(	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
MIP-1	NULL
«	NULL
and	NULL
FasL	NULL
)	NULL
,	NULL
the	NULL
mutant	NULL
NFAT	NULL
protein	NULL
was	NULL
fully	NULL
capable	NULL
of	NULL
inducing	NULL
transcription	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
implying	NULL
a	NULL
lack	NULL
of	NULL
requirement	NULL
for	NULL
cooperative	NULL
interactions	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

As	NULL
discussed	NULL
above	NULL
,	NULL
the	NULL
predominant	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
is	NULL
the	NULL
quasi-palindromic	NULL
x3	NULL
site	NULL
,	NULL
which	NULL
resembles	NULL
an	NULL
NF-xB/	NULL
Rel	NULL
binding	NULL
site	NULL
(	NULL
Goldfeld	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
TNFx	NULL
gene	NULL
falls	NULL
into	NULL
the	NULL
NFAT	NULL
:	NULL
AP-1-independent	NULL
category	NULL
raises	NULL
the	NULL
interesting	NULL
possibility	NULL
that	NULL
NFAT	NULL
:	NULL
AP-l-independent	NULL
genes	NULL
may	NULL
characteristically	NULL
contain	NULL
such	NULL
dimeric	NULL
binding	NULL
sites	NULL
for	NULL
NFAT	NULL
.	NULL

Alternatively	NULL
,	NULL
NFAT	NULL
may	NULL
utilise	NULL
other	NULL
non-AP-1	NULL
partners	NULL
such	NULL
as	NULL
GATA	NULL
proteins	NULL
(	NULL
see	NULL
previous	NULL
section	NULL
)	NULL
at	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
NFAT	NULL
:	NULL
AP-1-independent	NULL
genes	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
while	NULL
strict	NULL
physical	NULL
cooperativity	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
not	NULL
required	NULL
,	NULL
AP-1	NULL
family	NULL
members	NULL
do	NULL
cooperate	NULL
functionally	NULL
with	NULL
NFAT	NULL
to	NULL
promote	NULL
TNFa	NULL
gene	NULL
transcription	NULL
(	NULL
Falvo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Immediately	NULL
adjacent	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
ATF2-Jun	NULL
heterodimers	NULL
,	NULL
factors	NULL
which	NULL
cooperate	NULL
functionally	NULL
with	NULL
NFAT	NULL
dimers	NULL
bound	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
cells	NULL
and	NULL
stimulation	NULL
conditions	NULL
,	NULL
these	NULL
dimers	NULL
cooperate	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
proximal	NULL
TNFx	NULL
promoter	NULL
,	NULL
to	NULL
form	NULL
enhanceosome	NULL
complexes	NULL
that	NULL
drive	NULL
TNFx	NULL
gene	NULL
transcription	NULL
(	NULL
Falvo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
see	NULL
review	NULL
by	NULL
Chinenovy	NULL
and	NULL
Kerppola	NULL
in	NULL
this	NULL
issue	NULL
)	NULL
.	NULL

NFAT	NULL
target	NULL
genes	NULL
in	NULL
non-immune	NULL
cells	NULL
It	NULL
is	NULL
likely	NULL
that	NULL
many	NULL
NFAT-dependent	NULL
genes	NULL
in	NULL
cell	NULL
types	NULL
outside	NULL
the	NULL
immune	NULL
system	NULL
are	NULL
regulated	NULL
by	NULL
NFAT	NULL
nuclear	NULL
partners	NULL
other	NULL
than	NULL
AP-1	NULL
.	NULL

Suggested	NULL
genes	NULL
include	NULL
the	NULL
atrial	NULL
natriuretic	NULL
factor	NULL
gene	NULL
and	NULL
the	NULL
b-type	NULL
natriuretic	NULL
peptide	NULL
gene	NULL
in	NULL
cardiomyocytes	NULL
(	NULL
Molkentin	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
genes	NULL
controlling	NULL
the	NULL
slow	NULL
twitch	NULL
programme	NULL
in	NULL
skeletal	NULL
muscle	NULL
fibres	NULL
(	NULL
Chin	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
and	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
inositol	NULL
trisphosphate	NULL
receptor	NULL
in	NULL
hippocampal	NULL
cells	NULL
(	NULL
Graef	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
Biological	NULL
outcomes	NULL
of	NULL
NFAT	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
AP-1	NULL
It	NULL
seems	NULL
very	NULL
likely	NULL
that	NULL
even	NULL
in	NULL
a	NULL
single	NULL
cell	NULL
type	NULL
,	NULL
NFAT	NULL
proteins	NULL
elicit	NULL
different	NULL
programmes	NULL
of	NULL
gene	NULL
expression	NULL
depending	NULL
on	NULL
whether	NULL
AP-1	NULL
proteins	NULL
or	NULL
other	NULL
cooperating	NULL
transcription	NULL
factor	NULL
are	NULL
activated	NULL
at	NULL
the	NULL
same	NULL
time	NULL
.	NULL

Some	NULL
biological	NULL
responses	NULL
that	NULL
could	NULL
potentially	NULL
be	NULL
regulated	NULL
in	NULL
this	NULL
manner	NULL
are	NULL
described	NULL
below	NULL
.	NULL

T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
Development	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
involves	NULL
opposing	NULL
processes	NULL
of	NULL
negative	NULL
and	NULL
positive	NULL
selection	NULL
that	NULL
eliminate	NULL
strongly	NULL
self-reactive	NULL
cells	NULL
that	NULL
might	NULL
mediate	NULL
autoimmune	NULL
responses	NULL
,	NULL
and	NULL
permit	NULL
survival	NULL
and	NULL
maturation	NULL
of	NULL
cells	NULL
capable	NULL
of	NULL
recognizing	NULL
foreign	NULL
antigens	NULL
in	NULL
the	NULL
context	NULL
of	NULL
self	NULL
major	NULL
histocompatability	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

High-affinity	NULL
interaction	NULL
of	NULL
immature	NULL
thymocytes	NULL
with	NULL
MHC/antigen	NULL
complexes	NULL
lead	NULL
to	NULL
negative	NULL
selection	NULL
while	NULL
low	NULL
affinity	NULL
interactions	NULL
result	NULL
in	NULL
positive	NULL
selection	NULL
and	NULL
maturation	NULL
.	NULL

Several	NULL
findings	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
NFAT	NULL
in	NULL
positive	NULL
selection	NULL
:	NULL
NFAT4	NULL
is	NULL
the	NULL
major	NULL
NFAT	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
and	NULL
NFAT4	NULL
--	NULL
mice	NULL
show	NULL
a	NULL
moderate	NULL
impairment	NULL
of	NULL
positive	NULL
selection	NULL
(	NULL
Oukka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
;	NULL
inhibition	NULL
of	NULL
NFAT	NULL
activation	NULL
with	NULL
the	NULL
calcineurin	NULL
inhibitor	NULL
cyclosporin	NULL
A	NULL
blocks	NULL
positive	NULL
selection	NULL
(	NULL
Gao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
;	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
constitutively-active	NULL
form	NULL
of	NULL
calcineurin	NULL
in	NULL
a	NULL
transgenic	NULL
mouse	NULL
increases	NULL
sensitivity	NULL
to	NULL
a	NULL
signaling	NULL
through	NULL
the	NULL
TCR	NULL
and	NULL
results	NULL
in	NULL
increased	NULL
positive	NULL
selection	NULL
(	NULL
Hayden-Martinez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

While	NULL
positive	NULL
selection	NULL
shows	NULL
a	NULL
preferential	NULL
requirement	NULL
for	NULL
calcium	NULL
signaling	NULL
,	NULL
negative	NULL
selection	NULL
requires	NULL
stimulation	NULL
of	NULL
both	NULL
the	NULL
TCR	NULL
and	NULL
the	NULL
costimulatory	NULL
receptor	NULL
CD28	NULL
,	NULL
which	NULL
induces	NULL
JNK	NULL
activation	NULL
(	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

CD28-deficient	NULL
mice	NULL
show	NULL
defects	NULL
in	NULL
negative	NULL
selection	NULL
,	NULL
and	NULL
inhibiting	NULL
the	NULL
interaction	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
ligands	NULL
,	NULL
B7.1	NULL
and	NULL
B7.2	NULL
(	NULL
CD80	NULL
and	NULL
CD86	NULL
)	NULL
,	NULL
results	NULL
in	NULL
decreased	NULL
thymocyte	NULL
apoptosis	NULL
(	NULL
Noel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Samoilova	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
difference	NULL
in	NULL
the	NULL
balance	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
activation	NULL
and	NULL
cooperation	NULL
may	NULL
determine	NULL
the	NULL
initiation	NULL
of	NULL
programmes	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
immature	NULL
thymocytes	NULL
,	NULL
that	NULL
lead	NULL
to	NULL
either	NULL
cell	NULL
survival	NULL
(	NULL
positive	NULL
selection	NULL
)	NULL
or	NULL
cell	NULL
death	NULL
(	NULL
negative	NULL
selection	NULL
)	NULL
.	NULL

Supporting	NULL
this	NULL
hypothesis	NULL
,	NULL
cooperation	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
required	NULL
for	NULL
FasL	NULL
expression	NULL
,	NULL
and	NULL
potentiation	NULL
of	NULL
activation-induced	NULL
cell	NULL
death	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
process	NULL
analogous	NULL
to	NULL
negative	NULL
selection	NULL
,	NULL
is	NULL
only	NULL
induced	NULL
by	NULL
NFAT1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cooperative	NULL
interaction	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
Macian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

Th1-Th2	NULL
differentiation	NULL
in	NULL
the	NULL
periphery	NULL
As	NULL
outlined	NULL
earlier	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
respond	NULL
to	NULL
antigen	NULL
stimulation	NULL
by	NULL
differentiating	NULL
into	NULL
distinct	NULL
subsets	NULL
of	NULL
effector	NULL
cells	NULL
that	NULL
are	NULL
characterized	NULL
by	NULL
differing	NULL
patterns	NULL
of	NULL
cytokine	NULL
expression	NULL
.	NULL

Thl1	NULL
cells	NULL
produce	NULL
IFN-y	NULL
while	NULL
2485	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2486	NULL
Th2	NULL
cells	NULL
express	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
.	NULL

As	NULL
described	NULL
in	NULL
the	NULL
previous	NULL
section	NULL
,	NULL
NFAT	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
in	NULL
transcription	NULL
of	NULL
all	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
.	NULL

Chromatin	NULL
immunoprecipitation	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
NFAT1	NULL
binds	NULL
to	NULL
sites	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
a	NULL
distal	NULL
IL-4	NULL
enhancer	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
;	NULL
conversely	NULL
NFAT	NULL
binds	NULL
to	NULL
sites	NULL
in	NULL
the	NULL
IFN-y	NULL
promoter	NULL
in	NULL
Thl	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
accessibility	NULL
of	NULL
these	NULL
regulatory	NULL
regions	NULL
to	NULL
NFAT	NULL
is	NULL
determined	NULL
by	NULL
changes	NULL
in	NULL
chromatin	NULL
structure	NULL
occurring	NULL
during	NULL
T	NULL
cell	NULL
differentiation	NULL
(	NULL
Agarwal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

As	NULL
also	NULL
described	NULL
above	NULL
,	NULL
NFAT	NULL
:	NULL
AP-1	NULL
cooperation	NULL
is	NULL
also	NULL
required	NULL
for	NULL
transcription	NULL
of	NULL
both	NULL
Thl	NULL
and	NULL
Th2	NULL
cytokine	NULL
genes	NULL
;	NULL
thus	NULL
the	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interaction	NULL
may	NULL
be	NULL
globally	NULL
important	NULL
for	NULL
T	NULL
helper	NULL
cell	NULL
differentiation	NULL
without	NULL
necessarily	NULL
playing	NULL
a	NULL
selective	NULL
role	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
Thl-Th2	NULL
decision	NULL
depends	NULL
on	NULL
the	NULL
availability	NULL
of	NULL
specific	NULL
AP-1	NULL
partners	NULL
for	NULL
NFAT	NULL
:	NULL
specifically	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
Th2	NULL
cells	NULL
preferentially	NULL
upregulate	NULL
a	NULL
particular	NULL
AP-1	NULL
family	NULL
member	NULL
,	NULL
JunB	NULL
,	NULL
which	NULL
participates	NULL
in	NULL
IL-4	NULL
promoter	NULL
induction	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

A	NULL
region	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
that	NULL
confers	NULL
Th2	NULL
specificity	NULL
in	NULL
reporter	NULL
assays	NULL
and	NULL
transgenic	NULL
mice	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
a	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
site	NULL
(	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
although	NULL
the	NULL
particular	NULL
AP-1	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

Furthermore	NULL
,	NULL
JNK	NULL
1-	NULL
and	NULL
JNK	NULL
2-deficient	NULL
mice	NULL
show	NULL
impaired	NULL
Thl	NULL
development	NULL
,	NULL
suggesting	NULL
that	NULL
depending	NULL
on	NULL
the	NULL
conditions	NULL
,	NULL
impaired	NULL
AP-1	NULL
activation	NULL
may	NULL
preferentially	NULL
affect	NULL
with	NULL
the	NULL
Thl1	NULL
or	NULL
Th2	NULL
arm	NULL
of	NULL
T	NULL
helper	NULL
cell	NULL
development	NULL
(	NULL
Dong	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
,	NULL
2000	NULL
;	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Lymphocyte	NULL
tolerance|	NULL
anergy	NULL
Anergic	NULL
T	NULL
cells	NULL
show	NULL
a	NULL
profound	NULL
impairment	NULL
of	NULL
AP-1	NULL
activation	NULL
due	NULL
to	NULL
a	NULL
block	NULL
in	NULL
Ras	NULL
activation	NULL
that	NULL
results	NULL
in	NULL
defective	NULL
downstream	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
protein	NULL
kinases	NULL
(	NULL
Fields	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Nevertheless	NULL
anergic	NULL
cells	NULL
,	NULL
even	NULL
under	NULL
resting	NULL
conditions	NULL
,	NULL
maintain	NULL
levels	NULL
of	NULL
calcium	NULL
mobilization	NULL
that	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
NFAT	NULL
proteins	NULL
(	NULL
Healy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
an	NULL
in	NULL
vivo	NULL
model	NULL
of	NULL
B	NULL
cell	NULL
tolerance	NULL
.	NULL

Thus	NULL
the	NULL
productive	NULL
immune	NULL
response	NULL
in	NULL
lymphocytes	NULL
is	NULL
an	NULL
important	NULL
example	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
cooperativity	NULL
between	NULL
NFAT	NULL
and	NULL
AP-1	NULL
,	NULL
while	NULL
an	NULL
anergic/	NULL
tolerant	NULL
state	NULL
may	NULL
be	NULL
induced	NULL
when	NULL
the	NULL
balance	NULL
of	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
is	NULL
altered	NULL
.	NULL

NFATS5	NULL
NFATS	NULL
is	NULL
an	NULL
outlying	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
NFAT5	NULL
,	NULL
the	NULL
most	NULL
recent	NULL
addition	NULL
to	NULL
the	NULL
NFAT/	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
was	NULL
isolated	NULL
by	NULL
three	NULL
laboratories	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
high	NULL
degree	NULL
of	NULL
sequence	NULL
similarity	NULL
(	NULL
~43	NULL
%	NULL
)	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
Rel	NULL
homology	NULL
region	NULL
)	NULL
of	NULL
NFAT	NULL
proteins	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
;	NULL
Pan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
;	NULL
Trama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2000	NULL
)	NULL
.	NULL

In	NULL
Oncogene	NULL
addition	NULL
,	NULL
NFATS5	NULL
was	NULL
independently	NULL
cloned	NULL
in	NULL
a	NULL
yeast	NULL
one-hybrid	NULL
assay	NULL
as	NULL
TonEBP	NULL
,	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
tonicity	NULL
response	NULL
element	NULL
(	NULL
TonE	NULL
)	NULL
of	NULL
the	NULL
betaine	NULL
transporter	NULL
gene	NULL
(	NULL
Miyakawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
full	NULL
length	NULL
cDNA	NULL
encoding	NULL
NFATS	NULL
showed	NULL
that	NULL
this	NULL
new	NULL
Rel	NULL
protein	NULL
possessed	NULL
characteristics	NULL
that	NULL
were	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
NFATI-4	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

First	NULL
,	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NFATS5	NULL
does	NULL
not	NULL
support	NULL
cooperative	NULL
interactions	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
NFAT5	NULL
lacks	NULL
the	NULL
conserved	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
calcium-regulated	NULL
NFATs	NULL
:	NULL
neither	NULL
the	NULL
short	NULL
(	NULL
180	NULL
amino-acid	NULL
)	NULL
serine-rich	NULL
N-terminal	NULL
region	NULL
nor	NULL
the	NULL
long	NULL
(	NULL
~900	NULL
amino-acid	NULL
)	NULL
C-terminal	NULL
region	NULL
of	NULL
NFATS5	NULL
possesses	NULL
the	NULL
serine-rich	NULL
and	NULL
SPxx-repeat	NULL
motifs	NULL
characteristic	NULL
of	NULL
the	NULL
NFAT	NULL
regulatory	NULL
domains	NULL
.	NULL

Furthermore	NULL
,	NULL
immunocytochemical	NULL
and	NULL
biochemical	NULL
analysis	NULL
showed	NULL
that	NULL
NFAT5	NULL
is	NULL
completely	NULL
or	NULL
partially	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
neither	NULL
its	NULL
subcellular	NULL
distribution	NULL
nor	NULL
its	NULL
phosphorylation	NULL
state	NULL
are	NULL
detectably	NULL
altered	NULL
by	NULL
calcineurin	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

NFATS	NULL
mediates	NULL
the	NULL
cellular	NULL
response	NULL
to	NULL
osmotic	NULL
stress	NULL
There	NULL
is	NULL
considerable	NULL
evidence	NULL
that	NULL
NFATS5	NULL
is	NULL
responsible	NULL
for	NULL
mediating	NULL
the	NULL
spectrum	NULL
of	NULL
cellular	NULL
responses	NULL
to	NULL
osmotic	NULL
stress	NULL
.	NULL

In	NULL
osmotically-stressed	NULL
cells	NULL
,	NULL
NFATS5	NULL
levels	NULL
increase	NULL
,	NULL
it	NULL
becomes	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
its	NULL
migration	NULL
in	NULL
SDS	NULL
gels	NULL
is	NULL
altered	NULL
in	NULL
a	NULL
manner	NULL
reminiscent	NULL
of	NULL
phosphorylation	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
;	NULL
Miyakawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
NFATS5	NULL
binding	NULL
elements	NULL
are	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
osmotically-regulated	NULL
genes	NULL
(	NULL
e.g	NULL
.	NULL

aldose	NULL
reductase	NULL
,	NULL
the	NULL
betaine	NULL
transporter	NULL
and	NULL
the	NULL
sodium-myo-inositol	NULL
transporter	NULL
)	NULL
,	NULL
which	NULL
together	NULL
mediate	NULL
the	NULL
cell	NULL
's	NULL
transcriptional	NULL
response	NULL
to	NULL
osmotic	NULL
stress	NULL
(	NULL
see	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
encoded	NULL
by	NULL
these	NULL
genes	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
synthesis	NULL
or	NULL
transport	NULL
of	NULL
compatible	NULL
organic	NULL
osmolytes	NULL
such	NULL
as	NULL
betaine	NULL
,	NULL
taurine	NULL
and	NULL
myo-inositol	NULL
,	NULL
which	NULL
buffer	NULL
the	NULL
cell	NULL
against	NULL
osmotic	NULL
stress	NULL
(	NULL
reviewed	NULL
in	NULL
Burg	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

DNA-binding	NULL
by	NULL
NFATS	NULL
The	NULL
DNA-binding	NULL
domain	NULL
of	NULL
NFATS5	NULL
resembles	NULL
those	NULL
of	NULL
the	NULL
classical	NULL
NFAT	NULL
proteins	NULL
,	NULL
but	NULL
differs	NULL
in	NULL
two	NULL
major	NULL
respects	NULL
.	NULL

First	NULL
,	NULL
it	NULL
does	NULL
not	NULL
bind	NULL
cooperatively	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
to	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
sites	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
it	NULL
is	NULL
dimeric	NULL
in	NULL
solution	NULL
,	NULL
and	NULL
dimer	NULL
formation	NULL
is	NULL
obligatory	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2001	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
NFATS5	NULL
with	NULL
those	NULL
of	NULL
NFAT1-4	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Zhou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
shows	NULL
strong	NULL
conservation	NULL
of	NULL
essentially	NULL
all	NULL
the	NULL
residues	NULL
involved	NULL
in	NULL
contacting	NULL
DNA	NULL
,	NULL
but	NULL
effectively	NULL
no	NULL
conservation	NULL
of	NULL
residues	NULL
involved	NULL
in	NULL
making	NULL
contacts	NULL
with	NULL
Jun	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
Table	NULL
2	NULL
Binding	NULL
sites	NULL
for	NULL
NFAT5/TonEBP	NULL
in	NULL
osmotically-responsive	NULL
genes	NULL
Betaine	NULL
transporter	NULL
(	NULL
BGT	NULL
)	NULL
Dog	NULL
BGTI	NULL
Inositol	NULL
transporter	NULL
(	NULL
SMIT	NULL
)	NULL
SMIT	NULL
TonE-A	NULL
SMIT	NULL
TonE-B2	NULL
SMIT	NULL
TonE-C1	NULL
SMIT	NULL
TonE-C2	NULL
Aldose	NULL
reductase	NULL
(	NULL
AR	NULL
)	NULL
Human	NULL
AR	NULL
:	NULL
ORE-A	NULL
Mouse	NULL
AR	NULL
:	NULL
ORE-A	NULL
Rat	NULL
AR	NULL
:	NULL
ORE-A	NULL
Human	NULL
AR	NULL
:	NULL
ORE-B	NULL
Mouse	NULL
AR	NULL
:	NULL
ORE-B	NULL
Rat	NULL
AR	NULL
:	NULL
ORE-B	NULL
Human	NULL
AR	NULL
:	NULL
ORE-C	NULL
Mouse	NULL
AR	NULL
:	NULL
ORE-C	NULL
Rat	NULL
AR	NULL
:	NULL
ORE-C	NULL
Rabbit	NULL
AR	NULL
:	NULL
ORE-C	NULL
TACTTGGTGGAAAAGTCCAGCTGGTGATTCACCCT	NULL
GCAAGTGGAAAACTACCAAGA	NULL
TTAGCTGGAAAATTCCAAACA	NULL
AGAGCGTGGAAAATTACAGGCA	NULL
TGGCATGGAAAGTTACTCAAA	NULL
AGTTACATGGAAAAATATCTGGGCTAGTCTGTTCT	NULL
ACTCAAGTGGAAAATATCTGTTCTTTATAAATTTT	NULL
ATCCAAGTGGAAAATATCTGTTCTTTATAAATTTT	NULL
TCCCTCCTGGAAAATTTATACAGAACAGACTAGCC	NULL
CACCCCAGGGAAAATTTATAAAGAACAGATATTTT	NULL
CATCCCTGGGAAAATTTATAAAGAACAGATATTTT	NULL
CACCAAATGGAAAATCACCGGCATGGAGTTTAGAG	NULL
CACCGACTGGAAAATCACCAGAATGGGATTTAGAG	NULL
CACCAACTGGAAAATCACCAGAATGGCACTTAGAG	NULL
CAACGGAAAATCACCAG	NULL
domain	NULL
of	NULL
NFATS5	NULL
unambiguously	NULL
selected	NULL
consensus	NULL
NFAT-binding	NULL
sequences	NULL
(	NULL
TGGAAA	NULL
)	NULL
from	NULL
a	NULL
random	NULL
library	NULL
or	NULL
double	NULL
stranded	NULL
oligonucleotides	NULL
,	NULL
but	NULL
was	NULL
not	NULL
capable	NULL
of	NULL
cooperative	NULL
binding	NULL
with	NULL
AP-1	NULL
proteins	NULL
on	NULL
a	NULL
well-characterized	NULL
composite	NULL
NFAT	NULL
:	NULL
AP-1	NULL
site	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
mutation	NULL
of	NULL
candidate	NULL
DNA	NULL
contact	NULL
residues	NULL
abrogated	NULL
the	NULL
binding	NULL
of	NULL
NFATS5	NULL
to	NULL
DNA	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
2001	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Despite	NULL
its	NULL
strong	NULL
sequence	NULL
selectiv-ity	NULL
,	NULL
however	NULL
,	NULL
the	NULL
DNA-binding	NULL
affinity	NULL
of	NULL
NFATS	NULL
is	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
NFAT1	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1999a	NULL
,	NULL
b	NULL
)	NULL
,	NULL
possibly	NULL
reflecting	NULL
a	NULL
requirement	NULL
for	NULL
a	NULL
partner	NULL
protein	NULL
other	NULL
than	NULL
AP-1	NULL
.	NULL

Despite	NULL
the	NULL
similar	NULL
sizes	NULL
of	NULL
their	NULL
recombinant	NULL
DNA-binding	NULL
domains	NULL
,	NULL
the	NULL
NFATS5	NULL
:	NULL
DNA	NULL
complex	NULL
migrates	NULL
with	NULL
lower	NULL
affinity	NULL
than	NULL
the	NULL
NFATI	NULL
:	NULL
DNA	NULL
complex	NULL
in	NULL
native	NULL
gels	NULL
when	NULL
monomeric	NULL
DNA	NULL
sites	NULL
are	NULL
used	NULL
(	NULL
e.g	NULL
.	NULL

the	NULL
ARRE2	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
on	NULL
palindromic	NULL
DNA	NULL
elements	NULL
such	NULL
as	NULL
the	NULL
proximal	NULL
NF-xB	NULL
site	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
the	NULL
single	NULL
NFATS	NULL
:	NULL
DNA	NULL
complex	NULL
migrates	NULL
with	NULL
a	NULL
mobility	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
the	NULL
dimeric	NULL
complex	NULL
of	NULL
NFATI1I	NULL
with	NULL
DNA	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999a	NULL
)	NULL
.	NULL

The	NULL
isolated	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
NFATS5	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
full-length	NULL
NFATS5	NULL
in	NULL
cell	NULL
lysates	NULL
,	NULL
although	NULL
it	NULL
shows	NULL
no	NULL
interaction	NULL
with	NULL
NFATI1I	NULL
or	NULL
RelA	NULL
present	NULL
in	NULL
the	NULL
same	NULL
lysates	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999a	NULL
)	NULL
.	NULL

When	NULL
overexpressed	NULL
in	NULL
HeLa	NULL
cells	NULL
fused	NULL
to	NULL
a	NULL
nuclear	NULL
export	NULL
sequence	NULL
,	NULL
the	NULL
NFATS5	NULL
DNA	NULL
binding	NULL
domain	NULL
retained	NULL
endogenous	NULL
NFATS5	NULL
in	NULL
the	NULL
cyoplasm	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19992	NULL
)	NULL
,	NULL
overriding	NULL
its	NULL
natural	NULL
localization	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999b	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
NFATS5	NULL
was	NULL
dimeric	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

More	NULL
recently	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2001	NULL
,	NULL
sub-mitted	NULL
)	NULL
,	NULL
gel	NULL
filtration	NULL
studies	NULL
have	NULL
confirmed	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
NFATS	NULL
forms	NULL
a	NULL
dimer	NULL
in	NULL
solution	NULL
while	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
NFATI	NULL
is	NULL
monomeric	NULL
.	NULL

Co-expression	NULL
of	NULL
Myc-	NULL
and	NULL
HA-	NULL
tagged	NULL
forms	NULL
of	NULL
NFATS5	NULL
in	NULL
cells	NULL
revealed	NULL
that	NULL
full-length	NULL
NFATS	NULL
is	NULL
also	NULL
dimeric	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
osmotically-	NULL
stressed	NULL
cells	NULL
.	NULL

Alignment	NULL
of	NULL
the	NULL
C-terminal	NULL
regions	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
regions	NULL
of	NULL
Rel/	NULL
p50	NULL
and	NULL
NFATS	NULL
indicates	NULL
that	NULL
the	NULL
dimer	NULL
contact	NULL
residues	NULL
conserved	NULL
throughout	NULL
the	NULL
NF-xB/	NULL
Rel	NULL
family	NULL
are	NULL
also	NULL
conserved	NULL
in	NULL
NFATS5	NULL
.	NULL

Mutations	NULL
of	NULL
these	NULL
conserved	NULL
residues	NULL
abrogated	NULL
not	NULL
only	NULL
dimerization	NULL
but	NULL
also	NULL
the	NULL
DNA-binding	NULL
of	NULL
NFAT5	NULL
,	NULL
indicating	NULL
that	NULL
like	NULL
NF-xB/	NULL
Rel	NULL
proteins	NULL
,	NULL
NFATS5	NULL
binds	NULL
DNA	NULL
as	NULL
an	NULL
obligate	NULL
dimer	NULL
and	NULL
the	NULL
conserved	NULL
residues	NULL
in	NULL
the	NULL
dimerization	NULL
interface	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
.	NULL

When	NULL
co-expressed	NULL
with	NULL
an	NULL
NFAT5S	NULL
reporter	NULL
,	NULL
the	NULL
isolated	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
NFATS5	NULL
behaved	NULL
as	NULL
a	NULL
specific	NULL
and	NULL
powerful	NULL
dominant	NULL
negative	NULL
capable	NULL
of	NULL
blocking	NULL
NFAT5S-mediated	NULL
reporter	NULL
activity	NULL
,	NULL
but	NULL
not	NULL
NFAT	NULL
or	NULL
NF-xB	NULL
reporter	NULL
activity	NULL
.	NULL

This	NULL
dominant-negative	NULL
function	NULL
was	NULL
strongly	NULL
disrupted	NULL
by	NULL
mutations	NULL
that	NULL
impaired	NULL
dimerization	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
transcriptional	NULL
function	NULL
of	NULL
NFATS5	NULL
required	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
dimeric	NULL
transactivation	NULL
domain	NULL
facilitated	NULL
by	NULL
the	NULL
strong	NULL
dimerization	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Lopez-Rodriguez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
2001	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Final	NULL
remarks	NULL
It	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
calcium-regulated	NULL
NFAT	NULL
proteins	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
regulating	NULL
inducible	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
and	NULL
that	NULL
they	NULL
also	NULL
have	NULL
important	NULL
biological	NULL
functions	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
both	NULL
during	NULL
development	NULL
and	NULL
in	NULL
the	NULL
adult	NULL
animal	NULL
.	NULL

However	NULL
much	NULL
still	NULL
remains	NULL
to	NULL
be	NULL
understood	NULL
.	NULL

While	NULL
many	NULL
of	NULL
the	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
NFAT	NULL
proteins	NULL
during	NULL
the	NULL
productive	NULL
immune	NULL
response	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
their	NULL
target	NULL
genes	NULL
in	NULL
other	NULL
tissues	NULL
and	NULL
during	NULL
other	NULL
biological	NULL
processes	NULL
remain	NULL
largely	NULL
unknown	NULL
.	NULL

Whether	NULL
these	NULL
proteins	NULL
function	NULL
with	NULL
AP-1	NULL
or	NULL
non-AP-1	NULL
partner	NULL
proteins	NULL
in	NULL
non-immune	NULL
cell	NULL
types	NULL
also	NULL
remains	NULL
unclear	NULL
.	NULL

If	NULL
the	NULL
bulk	NULL
of	NULL
NFAT	NULL
functions	NULL
in	NULL
non-immune	NULL
cells	NULL
were	NULL
controlled	NULL
by	NULL
partner	NULL
proteins	NULL
other	NULL
than	NULL
AP-1	NULL
,	NULL
it	NULL
might	NULL
be	NULL
feasible	NULL
to	NULL
manipulate	NULL
the	NULL
immune	NULL
response	NULL
pharmacologically	NULL
by	NULL
inhibiting	NULL
the	NULL
NFAT	NULL
:	NULL
AP-1	NULL
interaction	NULL
.	NULL

2487	NULL
Oncogene	NULL
NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
2488	NULL
Acknowledgments	NULL
We	NULL
thank	NULL
Lin	NULL
Chen	NULL
for	NULL
Figure	NULL
3	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
CA42471	NULL
and	NULL
AI40127	NULL
(	NULL
to	NULL
A	NULL
Rao	NULL
)	NULL
and	NULL
by	NULL
a	NULL
References	NULL
Agarwal	NULL
S	NULL
,	NULL
Avni	NULL
O	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
12	NULL
,	NULL
643-652	NULL
.	NULL

Altman	NULL
A	NULL
,	NULL
Isakov	NULL
N	NULL
and	NULL
Baier	NULL
G.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
21	NULL
,	NULL
567-573	NULL
.	NULL

Aramburu	NULL
J	NULL
,	NULL
Garcia-Cozar	NULL
F	NULL
,	NULL
Raghavan	NULL
A	NULL
,	NULL
Okamura	NULL
H	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Hogan	NULL
PG	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

,	NULL
1	NULL
,	NULL
627-637	NULL
.	NULL

Aramburu	NULL
J	NULL
,	NULL
Yaffe	NULL
MB	NULL
,	NULL
Lopez-Rodriguez	NULL
C	NULL
,	NULL
Cantley	NULL
LC	NULL
,	NULL
Hogan	NULL
PG	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
285	NULL
,	NULL
2129-2133	NULL
.	NULL

Avai	NULL
O	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
654-659	NULL
.	NULL

Avots	NULL
A	NULL
,	NULL
Buttmann	NULL
M	NULL
,	NULL
Chuypilo	NULL
S	NULL
,	NULL
Escher	NULL
C	NULL
,	NULL
Smola	NULL
U	NULL
,	NULL
Bannister	NULL
AJ	NULL
,	NULL
Rapp	NULL
UR	NULL
,	NULL
Kouzarides	NULL
T	NULL
and	NULL
Serfling	NULL
E.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
10	NULL
,	NULL
515-524	NULL
.	NULL

Beals	NULL
CR	NULL
,	NULL
Clipstone	NULL
NA	NULL
,	NULL
Ho	NULL
SN	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
19972	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
,	NULL
11	NULL
,	NULL
824-834	NULL
.	NULL

Beals	NULL
CR	NULL
,	NULL
Sheridan	NULL
CM	NULL
,	NULL
Turck	NULL
CW	NULL
,	NULL
Gardner	NULL
P	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1997b	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
275	NULL
,	NULL
1930-1933	NULL
.	NULL

Bert	NULL
AG	NULL
,	NULL
Burrows	NULL
J	NULL
,	NULL
Hawwari	NULL
A	NULL
,	NULL
Vadas	NULL
MA	NULL
and	NULL
Cockerill	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
165	NULL
,	NULL
5646-5655	NULL
.	NULL

Bodor	NULL
J	NULL
and	NULL
Habener	NULL
JF	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
9544	NULL
9551	NULL
.	NULL

Burg	NULL
MB	NULL
,	NULL
Kwon	NULL
ED	NULL
and	NULL
Kultz	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Ann	NULL
.	NULL

Rev	NULL
.	NULL

Phsyiol	NULL
.	NULL

,	NULL
59	NULL
,	NULL
437-455	NULL
.	NULL

Burke	NULL
TF	NULL
,	NULL
Casolaro	NULL
V	NULL
and	NULL
Georas	NULL
SN	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

,	NULL
270.	NULL
,	NULL
1016-1023	NULL
.	NULL

Chen	NULL
L	NULL
,	NULL
Glover	NULL
JNM	NULL
,	NULL
Hogan	NULL
PG	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Harrison	NULL
SC	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
392	NULL
,	NULL
42-48	NULL
.	NULL

Chen	NULL
L.	NULL
Oakley	NULL
MG	NULL
,	NULL
Glover	NULL
JN	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Dervan	NULL
PB	NULL
,	NULL
Hogan	NULL
PG	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Verdine	NULL
GL	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
5	NULL
,	NULL
882	NULL
889	NULL
.	NULL

Chin	NULL
ER	NULL
,	NULL
Olson	NULL
EN	NULL
,	NULL
Richardson	NULL
JA	NULL
,	NULL
Yano	NULL
Q	NULL
,	NULL
Humphries	NULL
C	NULL
,	NULL
Shelton	NULL
JM	NULL
,	NULL
Wu	NULL
H	NULL
,	NULL
Zhu	NULL
WG	NULL
,	NULL
Basselduby	NULL
R	NULL
and	NULL
Williams	NULL
RS	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
12	NULL
,	NULL
2499-2509	NULL
.	NULL

Chow	NULL
CW	NULL
and	NULL
Davis	NULL
RJ	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
20	NULL
,	NULL
702-712	NULL
.	NULL

Chow	NULL
CW	NULL
,	NULL
Dong	NULL
C	NULL
,	NULL
Flavell	NULL
RA	NULL
and	NULL
Davis	NULL
RJ	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Mol	NULL
,	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
20	NULL
,	NULL
5227-5234	NULL
.	NULL

Chow	NULL
CW	NULL
,	NULL
Rincon	NULL
M	NULL
,	NULL
Cavanagh	NULL
J	NULL
,	NULL
Dickens	NULL
M	NULL
and	NULL
Davis	NULL
RJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
278	NULL
,	NULL
1638-1641	NULL
.	NULL

Chow	NULL
CW	NULL
,	NULL
Rincon	NULL
M	NULL
and	NULL
Davis	NULL
RJ	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
2300-2307	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Bert	NULL
Ag	NULL
,	NULL
Jenkins	NULL
F	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Shannon	NULL
MF	NULL
and	NULL
Vadas	NULL
MA	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
2071-2079	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Roberts	NULL
D	NULL
and	NULL
Vadas	NULL
MA	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
96	NULL
,	NULL
15097-15102	NULL
.	NULL

Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
96	NULL
,	NULL
611-614.	NULL
del	NULL
Arco	NULL
PG	NULL
,	NULL
Martinez-Martinez	NULL
S	NULL
,	NULL
Maldonado	NULL
JL	NULL
,	NULL
Ortega-Perez	NULL
I	NULL
and	NULL
Redondo	NULL
JM	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
275	NULL
,	NULL
13872-13878	NULL
.	NULL

Delapompa	NULL
JL	NULL
,	NULL
Timmerman	NULL
LA	NULL
,	NULL
Takimoto	NULL
H	NULL
,	NULL
Yoshida	NULL
H	NULL
,	NULL
Elia	NULL
AJ	NULL
,	NULL
Samper	NULL
E	NULL
,	NULL
Potter	NULL
J	NULL
,	NULL
Wakeham	NULL
A	NULL
,	NULL
Marengere	NULL
L	NULL
,	NULL
Langille	NULL
BL	NULL
,	NULL
Crabtree	NULL
GR	NULL
and	NULL
Mak	NULL
TW	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
392	NULL
,	NULL
182-186	NULL
.	NULL

Diebold	NULL
RJ	NULL
,	NULL
Rajaram	NULL
N	NULL
,	NULL
Leonard	NULL
DA	NULL
and	NULL
Kerppola	NULL
TK	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
95	NULL
,	NULL
7915-7920	NULL
.	NULL

Dolmetsch	NULL
RE	NULL
,	NULL
Lewis	NULL
RS	NULL
,	NULL
Goodnow	NULL
CC	NULL
and	NULL
Healy	NULL
JI	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
386	NULL
,	NULL
855-858	NULL
.	NULL

Dong	NULL
C	NULL
,	NULL
Yang	NULL
DD	NULL
,	NULL
Tournier	NULL
C	NULL
,	NULL
Whitmarsh	NULL
AJ	NULL
,	NULL
Xu	NULL
J	NULL
,	NULL
Davis	NULL
RJ	NULL
and	NULL
Flavell	NULL
RA	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
405	NULL
,	NULL
91-94	NULL
.	NULL

Oncogene	NULL
special	NULL
fellowship	NULL
from	NULL
the	NULL
Leukemia	NULL
and	NULL
Lymphoma	NULL
Society	NULL
(	NULL
to	NULL
C	NULL
Lopez-Rodriguez	NULL
)	NULL
.	NULL

Dong	NULL
C	NULL
,	NULL
Yang	NULL
DD	NULL
,	NULL
Wysk	NULL
M	NULL
,	NULL
Whitmarsh	NULL
AJ	NULL
,	NULL
Davis	NULL
RJ	NULL
and	NULL
Flavell	NULL
RA	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
282	NULL
,	NULL
2092-2095	NULL
.	NULL

Duncliffe	NULL
KN	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Vadas	NULL
MA	NULL
and	NULL
Cockerill	NULL
PN	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
175-185	NULL
.	NULL

Falvo	NULL
JV	NULL
,	NULL
Uglialoro	NULL
AM	NULL
,	NULL
Brinkman	NULL
BMN	NULL
,	NULL
Merika	NULL
M	NULL
,	NULL
Parekh	NULL
BS	NULL
,	NULL
Tsai	NULL
EY	NULL
,	NULL
King	NULL
HC	NULL
,	NULL
Morielli	NULL
AD	NULL
,	NULL
Peralta	NULL
EG	NULL
,	NULL
Maniatis	NULL
T	NULL
,	NULL
Thanos	NULL
D	NULL
and	NULL
Goldfeld	NULL
AE	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
20	NULL
,	NULL
2239-2247	NULL
.	NULL

Feske	NULL
S	NULL
,	NULL
Draeger	NULL
R	NULL
,	NULL
Peter	NULL
HH	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Immunobiol	NULL
.	NULL

,	NULL
202	NULL
,	NULL
134-150	NULL
.	NULL

Fields	NULL
PE	NULL
,	NULL
Gajewski	NULL
TF	NULL
and	NULL
Fitch	NULL
FW	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
271	NULL
,	NULL
1276-1278	NULL
.	NULL

Fischer	NULL
MB	NULL
,	NULL
Hauber	NULL
I	NULL
,	NULL
Eggenbauer	NULL
H	NULL
,	NULL
Thon	NULL
V	NULL
,	NULL
Vogel	NULL
E	NULL
,	NULL
Schaffer	NULL
E	NULL
,	NULL
Lokaj	NULL
J	NULL
,	NULL
Litzman	NULL
J	NULL
,	NULL
Wolf	NULL
HM	NULL
,	NULL
Mannhalter	NULL
JW	NULL
and	NULL
Eibl	NULL
MM	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
,	NULL
4234-4241	NULL
.	NULL

Gao	NULL
EK	NULL
,	NULL
Lo	NULL
D	NULL
,	NULL
Cheney	NULL
R	NULL
,	NULL
Kanagawa	NULL
O	NULL
and	NULL
Sprent	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
336	NULL
,	NULL
176-179	NULL
.	NULL

Garcia-Rodriguez	NULL
C	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
30	NULL
,	NULL
2432-2436	NULL
.	NULL

Garcia-Cozar	NULL
FJ	NULL
,	NULL
Okamura	NULL
H	NULL
,	NULL
Aramburu	NULL
JF	NULL
,	NULL
Shaw	NULL
KTY	NULL
,	NULL
Pelletier	NULL
L	NULL
,	NULL
Showalter	NULL
R	NULL
,	NULL
Villafranca	NULL
E	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
23877-23883	NULL
.	NULL

Glover	NULL
JNM	NULL
and	NULL
Harrison	NULL
SC	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
373	NULL
,	NULL
257-261	NULL
.	NULL

Goldfeld	NULL
AE	NULL
,	NULL
McCaffrey	NULL
PG	NULL
,	NULL
Strominger	NULL
JL	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
1365-1379	NULL
.	NULL

Graef	NULL
IA	NULL
,	NULL
Mermelstein	NULL
PG	NULL
,	NULL
Stankunas	NULL
K	NULL
,	NULL
Neilson	NULL
JR	NULL
,	NULL
Deisseroth	NULL
K	NULL
,	NULL
Tsien	NULL
RW	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
401	NULL
,	NULL
703-708	NULL
.	NULL

Hayden-Martinez	NULL
K	NULL
,	NULL
Kane	NULL
LP	NULL
and	NULL
Hedrick	NULL
SM	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
165	NULL
,	NULL
3713-3721	NULL
.	NULL

Healy	NULL
JI	NULL
,	NULL
Dolmetsch	NULL
RE	NULL
,	NULL
Timmerman	NULL
LA	NULL
,	NULL
Cyster	NULL
JG	NULL
,	NULL
Thomas	NULL
ML	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Lewis	NULL
RS	NULL
and	NULL
Goodnow	NULL
CC	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
419-428	NULL
.	NULL

Himes	NULL
SR	NULL
,	NULL
Coles	NULL
LS	NULL
,	NULL
Reeves	NULL
R	NULL
and	NULL
Shannon	NULL
MF	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
5	NULL
,	NULL
479-489	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Hodge	NULL
MR	NULL
,	NULL
Rooney	NULL
JW	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
85	NULL
,	NULL
973-983	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Kim	NULL
JHJ	NULL
,	NULL
Rooney	NULL
JW	NULL
,	NULL
Spiegelman	NULL
BM	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
95	NULL
,	NULL
15537-15541	NULL
.	NULL

Hodge	NULL
MR	NULL
,	NULL
Chun	NULL
HJ	NULL
,	NULL
Rengarajan	NULL
J	NULL
,	NULL
Alt	NULL
A	NULL
,	NULL
Lieberson	NULL
R	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
274	NULL
,	NULL
1903-1905	NULL
.	NULL

Hoey	NULL
T	NULL
,	NULL
Sun	NULL
YL	NULL
,	NULL
Williamson	NULL
K	NULL
and	NULL
Xu	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
461-472	NULL
.	NULL

Iacobelli	NULL
M	NULL
,	NULL
Wachsman	NULL
W	NULL
and	NULL
McGuire	NULL
KL	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
165	NULL
,	NULL
860-868	NULL
.	NULL

Iniguez	NULL
MA	NULL
,	NULL
Martinez-Martinez	NULL
S	NULL
,	NULL
Punzon	NULL
C	NULL
,	NULL
Redondo	NULL
JM	NULL
and	NULL
Fresno	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
275	NULL
,	NULL
23627-23635	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Badalian	NULL
TM	NULL
,	NULL
Hogan	NULL
PG	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1995a	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
4138-4145	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Loh	NULL
C	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1995b	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
333-342	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
McCaffrey	NULL
PG	NULL
,	NULL
Miner	NULL
Z	NULL
,	NULL
Kerppola	NULL
TK	NULL
,	NULL
Lambert	NULL
JN	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Curran	NULL
T	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1993a	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
365	NULL
,	NULL
352-355	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
Miner	NULL
Z	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
151	NULL
,	NULL
837-848	NULL
.	NULL

Kiani	NULL
A	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Aramburu	NULL
J	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
12	NULL
,	NULL
359	NULL
372	NULL
.	NULL

Kinoshita	NULL
S	NULL
,	NULL
Su	NULL
LS	NULL
,	NULL
Amano	NULL
M	NULL
,	NULL
Timmerman	NULL
LA	NULL
,	NULL
Kaneshima	NULL
H	NULL
and	NULL
Nolan	NULL
GP	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
235-244	NULL
.	NULL

Klemm	NULL
JD	NULL
,	NULL
Beals	NULL
CR	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
638-644	NULL
.	NULL

Latinis	NULL
KM	NULL
,	NULL
Norian	NULL
LA	NULL
,	NULL
Eliason	NULL
SL	NULL
and	NULL
Koretzky	NULL
GA.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
,	NULL
31427-31434	NULL
.	NULL

Li	NULL
BY	NULL
,	NULL
Tournier	NULL
C	NULL
,	NULL
Davis	NULL
RJ	NULL
and	NULL
Flavell	NULL
RA	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
18	NULL
,	NULL
420-432	NULL
.	NULL

Li	NULL
W	NULL
,	NULL
Whaley	NULL
CD	NULL
,	NULL
Mondino	NULL
A	NULL
and	NULL
Mueller	NULL
DL	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
271	NULL
,	NULL
1272-1276	NULL
.	NULL

Liou	NULL
J	NULL
,	NULL
Kiefer	NULL
F	NULL
,	NULL
Dang	NULL
A	NULL
,	NULL
Hashimoto	NULL
A	NULL
,	NULL
Cobb	NULL
MH	NULL
,	NULL
Kurosaki	NULL
T	NULL
and	NULL
Weiss	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
12	NULL
,	NULL
399-408	NULL
.	NULL

Liu	NULL
J	NULL
,	NULL
Masuda	NULL
ES	NULL
,	NULL
Tsuruta	NULL
L	NULL
,	NULL
Arai	NULL
N	NULL
and	NULL
Arai	NULL
K.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
162	NULL
,	NULL
4755-4761	NULL
.	NULL

Loh	NULL
C	NULL
,	NULL
Shaw	NULL
KTY	NULL
,	NULL
Carew	NULL
J	NULL
,	NULL
Viola	NULL
JPB	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Perrino	NULL
BA	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
10884-10891	NULL
.	NULL

Lopez-Rodriguez	NULL
C	NULL
,	NULL
Aramburu	NULL
J	NULL
,	NULL
Rakeman	NULL
AS	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Gilbert	NULL
DJ	NULL
,	NULL
Thomas	NULL
S	NULL
,	NULL
Disteche	NULL
C	NULL
,	NULL
Jenkins	NULL
NA	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1999a	NULL
)	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symposia	NULL
on	NULL
Quantitative	NULL
Biology	NULL
,	NULL
64	NULL
,	NULL
517-526	NULL
.	NULL

Lopez-Rodriguez	NULL
C	NULL
,	NULL
Aramburu	NULL
J	NULL
,	NULL
Rakeman	NULL
AS	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1999b	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
96	NULL
,	NULL
7214-7219	NULL
.	NULL

Luo	NULL
C	NULL
,	NULL
Burgeon	NULL
E	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1996a	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
184	NULL
,	NULL
141-147	NULL
.	NULL

Luo	NULL
C	NULL
,	NULL
Shaw	NULL
KTY	NULL
,	NULL
Raghavan	NULL
A	NULL
,	NULL
Aramburu	NULL
J	NULL
,	NULL
Garcia-Cozar	NULL
F	NULL
,	NULL
Perrino	NULL
BA	NULL
,	NULL
Hogan	NULL
PG	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1996b	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

,	NULL
93	NULL
,	NULL
8907-8912	NULL
.	NULL

Macian	NULL
F	NULL
,	NULL
Garcia-Rodriguez	NULL
C	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
19	NULL
,	NULL
4783-4795	NULL
.	NULL

Macian	NULL
F	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
3645-3653	NULL
.	NULL

Masuda	NULL
ES	NULL
,	NULL
Naito	NULL
Y	NULL
,	NULL
Tokumitsu	NULL
H	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Saito	NULL
F	NULL
,	NULL
Hannum	NULL
C	NULL
,	NULL
Arai	NULL
K	NULL
and	NULL
Arai	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
2697-2706	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Goldfeld	NULL
AE	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
30445-30450	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Kerppola	NULL
TK	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Badalian	NULL
TM	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Lane	NULL
WS	NULL
,	NULL
Lambert	NULL
JN	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Hogan	NULL
PG	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
262	NULL
,	NULL
750-754	NULL
.	NULL

Miyakawa	NULL
H	NULL
,	NULL
Woo	NULL
SK	NULL
,	NULL
Dahl	NULL
SC	NULL
,	NULL
Handler	NULL
JS	NULL
and	NULL
Kwon	NULL
HM	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
96	NULL
,	NULL
2538-2542	NULL
.	NULL

Molkentin	NULL
JD	NULL
,	NULL
Lu	NULL
JR	NULL
,	NULL
Antos	NULL
CL	NULL
,	NULL
Markham	NULL
B	NULL
,	NULL
Richardson	NULL
J	NULL
,	NULL
Robbins	NULL
J	NULL
,	NULL
Grant	NULL
SR	NULL
and	NULL
Olson	NULL
EN	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
93	NULL
,	NULL
215-228	NULL
.	NULL

Musaro	NULL
A	NULL
,	NULL
McCullagh	NULL
KH	NULL
,	NULL
Naya	NULL
FJ	NULL
,	NULL
Olson	NULL
EN	NULL
and	NULL
Rosenthal	NULL
N.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
400	NULL
,	NULL
581-585	NULL
.	NULL

Neal	NULL
JW	NULL
and	NULL
Clipstone	NULL
NA	NULL
.	NULL

(	NULL
2001	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
276	NULL
,	NULL
3666-3673	NULL
.	NULL

Noel	NULL
PJ	NULL
,	NULL
Alegre	NULL
ML	NULL
,	NULL
Reiner	NULL
SL	NULL
and	NULL
Thompson	NULL
CB	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
187	NULL
,	NULL
131-138	NULL
.	NULL

Nolan	NULL
GP	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
,	NULL
795-798	NULL
.	NULL

Norian	NULL
LA	NULL
,	NULL
Latinis	NULL
KM	NULL
,	NULL
Eliason	NULL
SL	NULL
,	NULL
Lyson	NULL
K	NULL
,	NULL
Yang	NULL
CM	NULL
,	NULL
Ratliff	NULL
T	NULL
and	NULL
Koretzky	NULL
GA.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
164	NULL
,	NULL
4471-4480	NULL
.	NULL

Northrop	NULL
JP	NULL
,	NULL
Ho	NULL
SN	NULL
,	NULL
Chen	NULL
L	NULL
,	NULL
Thomas	NULL
DJ	NULL
,	NULL
Timmerman	NULL
LA	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Admon	NULL
A	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
369	NULL
,	NULL
497-502	NULL
.	NULL

Okamura	NULL
H	NULL
,	NULL
Aramburu	NULL
J	NULL
,	NULL
Garcia-Rodriguez	NULL
C	NULL
,	NULL
Viola	NULL
JPB	NULL
,	NULL
Raghavan	NULL
A	NULL
,	NULL
Tahiliani	NULL
M	NULL
,	NULL
Zhan	NULL
XL	NULL
,	NULL
Qin	NULL
J	NULL
,	NULL
Hogan	NULL
PG	NULL
and	NULL
Rao	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
,	NULL
6	NULL
,	NULL
539-550	NULL
.	NULL

Oukka	NULL
M	NULL
,	NULL
Ho	NULL
IC	NULL
,	NULL
Delabrousse	NULL
FC	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Grusby	NULL
MJ	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
295-304	NULL
.	NULL

Pan	NULL
S	NULL
,	NULL
Tsuruta	NULL
R	NULL
,	NULL
MAsuda	NULL
Es	NULL
,	NULL
Imamura	NULL
R	NULL
,	NULL
Bazan	NULL
F	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
and	NULL
Miyatake	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comms	NULL
.	NULL

,	NULL
272	NULL
,	NULL
765-776	NULL
.	NULL

Park	NULL
JC	NULL
,	NULL
Yaseen	NULL
NR	NULL
,	NULL
Hogan	NULL
PG	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Sharma	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
20653-20659	NULL
.	NULL

NFAT/AP-1	NULL
transcriptional	NULL
cooperation	NULL
F	NULL
Macian	NULL
et	NULL
al	NULL
Park	NULL
S	NULL
,	NULL
Uesugi	NULL
M	NULL
and	NULL
Verdine	NULL
GL	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
97	NULL
,	NULL
7130-7135	NULL
.	NULL

Peng	NULL
LP	NULL
,	NULL
Gerth	NULL
AJ	NULL
,	NULL
Ranger	NULL
AN	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
2001	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
14	NULL
,	NULL
13-20	NULL
.	NULL

Peterson	NULL
BR	NULL
,	NULL
Sun	NULL
LJ	NULL
and	NULL
Verdine	NULL
GL	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
,	NULL
13671-13676	NULL
.	NULL

Porter	NULL
CM	NULL
,	NULL
Havens	NULL
MA	NULL
and	NULL
Clipstone	NULL
NA	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Bio/	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
275	NULL
,	NULL
3543-3551	NULL
.	NULL

Ranger	NULL
AM	NULL
,	NULL
Gerstenfeld	NULL
LC	NULL
,	NULL
Wang	NULL
JX	NULL
,	NULL
Kon	NULL
T	NULL
,	NULL
Bae	NULL
HS	NULL
,	NULL
Gravallese	NULL
EM	NULL
,	NULL
Glimcher	NULL
MJ	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
191	NULL
,	NULL
9-21	NULL
.	NULL

Ranger	NULL
AM	NULL
,	NULL
Grusby	NULL
MJ	NULL
,	NULL
Hodge	NULL
MR	NULL
,	NULL
Gravallese	NULL
EM	NULL
,	NULL
Delabrousse	NULL
FC	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Mickanin	NULL
C	NULL
,	NULL
Baldwin	NULL
HS	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1998a	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
392	NULL
,	NULL
186-190	NULL
.	NULL

Ranger	NULL
AM	NULL
,	NULL
Oukka	NULL
M	NULL
,	NULL
Rengarajuan	NULL
J	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1998b	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
627-635	NULL
.	NULL

Rao	NULL
A	NULL
,	NULL
Luo	NULL
C	NULL
and	NULL
Hogan	NULL
PG	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
707-747	NULL
.	NULL

Rincon	NULL
M	NULL
,	NULL
Whitmarsh	NULL
A	NULL
,	NULL
Yang	NULL
DD	NULL
,	NULL
Weiss	NULL
L	NULL
,	NULL
Derijard	NULL
B	NULL
,	NULL
Jayaraj	NULL
P	NULL
,	NULL
Davis	NULL
RJ	NULL
and	NULL
Flavell	NULL
RA	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
188	NULL
,	NULL
1817-1830	NULL
.	NULL

Rooney	NULL
JW	NULL
,	NULL
Hoey	NULL
T	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
1995a	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
473-483	NULL
.	NULL

Rooney	NULL
JW	NULL
,	NULL
Sun	NULL
YL	NULL
,	NULL
Glimcher	NULL
LH	NULL
and	NULL
Hoey	NULL
T.	NULL
(	NULL
1995b	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
6299-6310	NULL
.	NULL

Samoilova	NULL
EB	NULL
,	NULL
Horton	NULL
JL	NULL
,	NULL
Bassiri	NULL
H	NULL
,	NULL
Zhang	NULL
H	NULL
,	NULL
Linsley	NULL
PS	NULL
,	NULL
Carding	NULL
SR	NULL
and	NULL
Chen	NULL
Y	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Int/	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
1663-1668	NULL
.	NULL

Schuh	NULL
K	NULL
,	NULL
Twardzik	NULL
T	NULL
,	NULL
Kneitz	NULL
B	NULL
,	NULL
Heyer	NULL
J	NULL
,	NULL
Schimpl	NULL
A	NULL
and	NULL
Serfling	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
188	NULL
,	NULL
1369-1373	NULL
.	NULL

Shaw	NULL
KTY	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Raghavan	NULL
A	NULL
,	NULL
Kim	NULL
J	NULL
,	NULL
Jain	NULL
JN	NULL
,	NULL
Park	NULL
JC	NULL
,	NULL
Sharma	NULL
S	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Hogan	NULL
PG	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
11205-11209	NULL
.	NULL

Shibasaki	NULL
F	NULL
,	NULL
Price	NULL
ER	NULL
,	NULL
Milan	NULL
D	NULL
and	NULL
McKeon	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
382	NULL
,	NULL
370-373	NULL
.	NULL

Sun	NULL
LJ	NULL
,	NULL
Peterson	NULL
BR	NULL
and	NULL
Verdine	NULL
GL	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
94	NULL
,	NULL
4919-4924	NULL
.	NULL

Sun	NULL
ZM	NULL
,	NULL
Arendt	NULL
CW	NULL
,	NULL
Ellmeier	NULL
W	NULL
,	NULL
Schaeffer	NULL
EM	NULL
,	NULL
Sunshine	NULL
MJ	NULL
,	NULL
Ganhi	NULL
L	NULL
,	NULL
Annes	NULL
J	NULL
,	NULL
Petrzilka	NULL
D	NULL
,	NULL
Kupfer	NULL
A	NULL
,	NULL
Schwartz-berg	NULL
PL	NULL
and	NULL
Littman	NULL
DR.	NULL
(	NULL
2000	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
404	NULL
,	NULL
402-407	NULL
.	NULL

Szabo	NULL
SJ	NULL
,	NULL
Kim	NULL
ST	NULL
,	NULL
Costs	NULL
GL	NULL
,	NULL
Zhang	NULL
XK	NULL
,	NULL
Fathman	NULL
CG	NULL
and	NULL
Glimcher	NULL
LH	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
100	NULL
,	NULL
655-669	NULL
.	NULL

Takemoto	NULL
N	NULL
,	NULL
Koyanonakagawa	NULL
N	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Arai	NULL
K	NULL
and	NULL
Yokota	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Int/	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
1329-1338	NULL
.	NULL

Timmerman	NULL
LA	NULL
,	NULL
Clipstone	NULL
NA	NULL
,	NULL
Ho	NULL
SN	NULL
,	NULL
Northrop	NULL
JP	NULL
and	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
383	NULL
,	NULL
837-840	NULL
.	NULL

Trama	NULL
J	NULL
,	NULL
Lu	NULL
QJ	NULL
,	NULL
Hawley	NULL
RG	NULL
and	NULL
Ho	NULL
SN	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
165	NULL
,	NULL
4884-4894	NULL
.	NULL

Tsai	NULL
EY	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Pesavento	NULL
PA	NULL
,	NULL
Rao	NULL
A	NULL
and	NULL
Goldfeld	NULL
AE	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
459-467	NULL
.	NULL

Villalba	NULL
M	NULL
,	NULL
Kasibhatla	NULL
S	NULL
,	NULL
Genestier	NULL
L	NULL
,	NULL
Mahboubi	NULL
A	NULL
,	NULL
Green	NULL
DR	NULL
and	NULL
Altman	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
163	NULL
,	NULL
5813-5819	NULL
.	NULL

Wenner	NULL
CA	NULL
,	NULL
Szabo	NULL
SJ	NULL
and	NULL
Murphy	NULL
KM	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
!	NULL

.	NULL

,	NULL
158	NULL
,	NULL
765-773	NULL
.	NULL

Werlen	NULL
G	NULL
,	NULL
Jacinto	NULL
E	NULL
,	NULL
Xia	NULL
Y	NULL
and	NULL
Karin	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
,	NULL
3101-3111	NULL
.	NULL

Yang	NULL
DD	NULL
,	NULL
Conze	NULL
D	NULL
,	NULL
Whitmarsh	NULL
AJ	NULL
,	NULL
Barrett	NULL
T	NULL
,	NULL
Davis	NULL
RJ	NULL
,	NULL
Rincon	NULL
M	NULL
and	NULL
Flavell	NULL
RA	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
575-585	NULL
.	NULL

Zhang	NULL
DH	NULL
,	NULL
Yang	NULL
LY	NULL
,	NULL
Cohn	NULL
L	NULL
,	NULL
Parkyn	NULL
L	NULL
,	NULL
Homer	NULL
R	NULL
,	NULL
Ray	NULL
P	NULL
and	NULL
Ray	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
11	NULL
,	NULL
473-482	NULL
.	NULL

Zhou	NULL
P	NULL
,	NULL
Sun	NULL
LJ	NULL
,	NULL
Dotsch	NULL
V	NULL
,	NULL
Wagner	NULL
G	NULL
and	NULL
Verdine	NULL
GL	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
92	NULL
,	NULL
687-696	NULL
.	NULL

Zhu	NULL
JY	NULL
and	NULL
McKeon	NULL
F.	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
398	NULL
,	NULL
256-260	NULL
.	NULL

Zhu	NULL
JY	NULL
,	NULL
Shibasaki	NULL
F	NULL
,	NULL
Price	NULL
R	NULL
,	NULL
Guillemot	NULL
JC	NULL
,	NULL
Yano	NULL
T	NULL
,	NULL
Dotsch	NULL
V	NULL
,	NULL
Wagner	NULL
G	NULL
,	NULL
Ferrara	NULL
P	NULL
and	NULL
McKeon	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
93	NULL
,	NULL
851-861	NULL
.	NULL

2489	NULL
Oncogene	NULL

